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Abstract 
 
Cell penetrating peptides (CPPs) like HIV1-TAT have the special property to traverse the 
cell membrane and to function as vectors for various macromolecular cargoes such as 
fluorophores, nucleotides, drugs, proteins, DNA, and peptide-nucleic acids, and even 
liposomes and magnetic nanoparticles. In spite of the fact that TAT peptides were 
intensively investigated, the exact internalization mechanism is still controversial. 
Descriptions of the internalization process range from energy-independent cell penetration 
of membranes to endocytic uptake: clathrin-independent endocytosis, caveolae-mediated 
endocytosis or macropinocytosis. The uptake mechanisms identified for TAT alone are 
valid also for cargoes that are introduced into the cells through coupling to the peptide. 
Experiments with genetically modified systems to suppress the endocytic internalization 
demonstrated that the transduction of TAT into living cells is not dependent on any 
endocytic or pinocytic events. Also, TAT was not excluded from cells that were 
transferred to 4 °C, a state where all potential endocytic pathways are inhibited. Recently, 
a pore formation, similar to the antibiotic peptides, was suggested by molecular dynamics 
simulations and black lipid experiments for TAT peptides. 
Altogether, a consensus regarding the uptake mode has not been reached. Despite the 
controversy and uncertainty regarding the uptake mechanism, the property of TAT to 
deliver non-permeable molecules into living cells makes it an attractive tool for biological 
sciences as well as medicine and biotechnology. It is therefore essential to identify 
precisely the criteria which can yield an efficient cell penetration with a high degree of 
drug transfer. To elucidate the non-endocytic entry routes and the transduction 
mechanism, one possibility is to analyse interaction of TAT peptides with model 
membrane systems. In this study we use giant unilamellar vesicles (GUVs) as cyto-
mimetic model system since the micrometer scale of the GUVs enables microscopic 
observation of these liposomes. 
A parameter, which directly would reflect possible aggregate formation preceding 
internalization, is the mobility of CPPs on the membrane surface. Aggregation, pore 
nucleation and micelle formation should be reflected in gross changes of the diffusion 
properties of the peptide within the membranes. These can most conveniently be studied 
by single molecule observation using fluorescence microscopy employing electron 
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multiplying CCD camera systems. Single fluorescently labelled molecules can be imaged 
microscopically as diffraction-limited spots. The intensity distribution of these spots may 
be approximated by a 2D Gaussian function. Thus, the position of the molecule as the very 
centre of the Gaussian can be determined with high precision by a fitting process. The 
localization precision may reach a few manometers under optimal conditions. Thereby, 
fluorescence microscopy allows following the traces of single molecules in time with a 
very high spatial precision. The technique has mostly been applied to analyse the 
movement of single receptors and lipid molecules in biological membranes, but was 
recently extended to study single-molecule mobility within solution and the interior of 
mammalian cells. In this study we applied high-speed single-particle tracking (SPT) and 
confocal laser scanning microscopy to systematically examine factors that affect 
membrane binding, mobility and penetration of fluorescence labelled TAT peptides in the 
GUVs with different composition.  
To focus onto interaction between TAT and lipids the first experiments were performed in 
sucrose/glucose solution with all ions excluded from the media. As a reference we first 
examined the mobility of fluorescent lipids within the GUV bilayer. As expected, lipid 
mobility varied clearly with the phase state of the membranes, whereas peptide mobility 
was independent on membrane hydrophobic core, but dependent on headgroup of lipids in 
the bilayer.  
CLSM experiments revealed that in GUVs formed by phosphatidylcholine (PC) and 
cholesterol no translocation of TAT peptides but just accumulation on the membrane. The 
same effect was observed also for anionic GUVs containing 15-30 mol % 
phosphatidylserine (PS). Additional SPT experiments and evaluation of diffusion 
coefficients revealed that TAT peptides “float” on neutral membranes and they are partial 
inserted in the headgroup of anionic bilayers.  The “floating” of peptides on neutral 
membranes and the slight immersion in the anionic bilayers were confirmed by Monte 
Carlo simulations. Introduction of a significant amount of anionic lipids (40 mol %) or 
lipids inducing locally a negative curvature into the membranes (20 mol %) affected TAT 
translocation across these membranes. Notably, we discovered that TAT peptides were not 
only able to directly penetrate such membranes in a passive manner, but they were also 
capable of forming physical pores, which could be passed by small but not large dye tracer 
molecules.  
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For the physiological relevance of the study, additional experiments in the presence of salt 
solutions were performed. CLSM experiments showed that physiological salt solution 
dramatically changed the TAT interaction with the GUV membrane. Binding of TAT to 
GUVs of all employed compositions was completely lost, and the peptides now efficiently 
translocated into the GUV interior. In confocal images no membrane staining was 
observable and dye release indicated again pore formation. Also the sensitive single 
molecule microscope did not detect any trace of peptides on the GUV surface. This result 
was obtained for neutral or anionic, liquid-ordered or liquid-disordered membranes. Also, 
there was no difference for GUVs without cholesterol or in case of other salt solutions at 
the same concentration, 100 mM (CaCl2, CaCO3 or PBS). 
The last chapter of this thesis comprises a study on the antimicrobial peptide NKCS, 
which supposedly acts by membrane pore formation. The experiments revealed 
similitudes in the action of antimicrobial NKCS with the cell penetrating TAT, but also 
certain differences. We observed that TAT peptides behave similar to NKCS, inducing 
pores in PE and anionic membranes (PS for TAT and PG for NKCS). A clear difference 
for these peptides was observed for GUVs prepared from phosphatidylcholine. CLSM 
experiments showed accumulation of TAT, but no interaction of NKCS with PC 
membranes. While for the CPP-TAT the ions from medium seemed to play a very 
important role for peptide translocation, NKCS activity was not affected by 100 mM salt 
solution. 
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Abbreviations 
 
AFM Atomic Force Microscopy 
AF-TAT Alexa Fluor 647-RRRQRRKKRG   
AF488 Alexa Fluor 488 
AOTF Acousto-Optic Tuneable Filters 
Bodipy-PC 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-
pentanoyl)-1-hehadecanoyl-sn-glicero-3-phosphocholine  
B-TAT Biotin-Ahx-YGRKKRRQRRR (biotinylated TAT) 
CaCl2 calcium chloride 
CaCO3   calcium carbonate 
CCD Charge Coupled Device 
CD Circular Dichroism 
chol cholesterol  
CLSM Confocal Laser Scanning Microscope 
CF carboxyfluorescein 
CPPs Cell-Penetrating Peptides 
CPZ chlorpromazine 
DIC Differential Interference Contrast  
DiI-C18 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine 
DOPC 1,2-dioleyl-sn-glycero-3-phosphocholine 
DOPE 1,2-dioleyl-sn-glycero-3-phosphoethanolamine 
DOPS 1,2-dioleoyl-sn-glycero-3-phospho-L-serine  
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine 
DPPE 1,2-dipalmitoyl-sn-gylcero-3-phosphoethanolamine  
DPPS 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine 
DSC Differential Scanning Calorimetry 
Dy-NKCS KILRGVSKKIMRTFLRRISKDILTGKK-C(Dy647-ME)-NH2 
Dy-NKCS[15-27] LRRISKDILTGKK-C(Dy647-ME)-NH2 
Dy-NKCS[15-27S] LRGISKKIDRTLK-C(Dy647-ME)-NH2 
EIPA 5-(N-ethyl-N-isopropyl)amiloride 
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EGFP Enhanced Green Fluorescent Protein  
EPR Electron Paramagnetic Resonance 
FCS Fluorescence Correlation Spectroscopy 
FITC fluorescein isothiocyanate 
FRAP Fluorescence Recovery After Photobleaching 
FRET Fluorescence Resonance Energy Transfer 
FTIR Fourier transformed infrared spectroscopy  
FWHM Full Width at Half Maximum 
GPI glycosylphosphatidylinositol 
GSLs glycosphingolipids  
GUVs Giant Unilamellar Vesicles 
ITO Indium-Tin-Oxide 
LUVs Large Unilamellar Vesicles 
LPS lipopolysaccharides  
LY Lucifer Yellow 
MβCD methyl-β-cyclodextrin 
MgCl2 magnesium chloride 
MLVs multilamellar vesicles 
MSD Mean Square Displacement  
NA Numerical Aperture  
NaCl sodium chloride 
NMR Nuclear Magnetic Resonance 
PA phosphatidic acid 
PI phosphatidylinositol  
PMT photomultiplier tube 
POPE 1-palmitoyl-2-oleoyl-sn-gylcero-3-phosphoethanolamine 
POPG 1-palmitoyl-2-oleoyl -sn-glycero-3-[phospho-rac-(1-glycerol)] 
PS phosphatidyl serine 
PTDs Protein Transduction Domains 
PBS phosphate buffered saline 
R-TAT TAMRA-RRRQRRKKRG (rhodamine-labelled TAT) 
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SANS Small Angle Neutron Scattering 
SAXS Small Angle X-ray Scattering 
SM sphingomyelin 
SMF single molecule fluorescence microscopy 
SNR signal-to-noise ratio 
SPT Single Particle Tracking 
SUVs Small Unilamellar Vesicles 
TAMRA tetramethyl-6-carboxyrhodamine 
TR-DHPE Texas Red-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 
TRITC tetramethyl rhodamine iso-thiocyanate 
ULVs unilamellar vesicles 
UV-VIS ultraviolet-visible 
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1. Introduction and general objectives 
 
In the past decade, specific peptides and proteins have been shown to penetrate cell 
membranes by a process called transduction [1], [2]. The peptide sequences, which could 
be identified as responsible for the translocation capability, were designated as protein 
transduction domains (PTDs) [3], cell-penetrating peptides (CPPs) [4] or Trojan horse 
peptides [5].  
CPPs have been demonstrated to enter a large number of cell types [3] and to function as 
vectors for various macromolecular cargoes such as fluorophores, nucleotides, drugs, 
proteins, DNA, and peptide-nucleic acids and even liposomes and magnetic nanoparticles 
[6]. 
Descriptions of the internalization process range from energy-independent cell penetration 
of membranes to endocytic uptake: clathrin-independent endocytosis [7]; [8], caveolae-
mediated endocytosis [9]; [2] or macropinocytosis [10]; [11]; [12]. Figure 1.1 shows the 
main endocytotic pathways of CPPs internalization.  
 
 
 Figure 1.1: Pathways of active entry into cells (adapted from [13]). Details are given in the text. 
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Active uptake of fluids and small particles occurs by macropinocytosis. This process 
consists in formation of large endocytic vesicles (macropinosomes) generated by actin-
driven circular ruffles of the plasma membrane. Most internalized cargoes are delivered to 
the early endosome via vesicular (clathrin- or caveolin-coated vesicles) or tubular 
intermediates (known as clathrin- and dynamin dependent carriers) that are derived from 
the plasma membrane. Clathrin is a cytosolic protein which has the property to form 
domains of the plasma membrane termed clathrin-coated pits. Dynamin is a GTPase 
involved in the scission of newly formed vesicles from the membrane (Figure 1.1). 
Caveolae are the most common reported non-clathrin coated plasma membrane vesicles 
and they consist of the cholesterol-binding protein caveolin with a bilayer enriched in 
cholesterol and glycolipids.  
Obviously, the internalization process varies for different CPPs. In general, however, the 
biophysical mechanism of the plasma membrane translocation of the CPPs is not well 
understood in its entire complexity. A highly charged cationic domain is common for most 
CPPs and essential for translocation. However, it is known that charged molecules usually 
do not cross the lipid bilayer by passive diffusion due to the high Born charging energy 
encountered in a medium with a low dielectric constant. Cells usually utilize special 
transport systems such as ion carriers, channels, and ATP-coupled pumps to regulate the 
flow of ions and charged molecules across their membranes. From a physico-chemical 
point of view, it is therefore very surprising that short peptides containing a high 
percentage of cationic amino acids can nevertheless cross the plasma membrane of living 
cells by pathways, which mostly appear to function without energy consumption. 
Complex formation of the cationic peptide with anionic cell surface components such as 
anionic lipid head groups or the proteoglycan heparan sulphate, which is present on the 
surface of most cell plasma membranes, could result in an electrically neutral complex, 
which might subsequently be taken up by adsorptive endocytosis [14], [15].  
Three mechanisms were suggested for charged peptides to cross the hydrophobic barrier 
of a biological membrane without utilizing an active transport system [16]. One possibility 
is direct membrane penetration. An alternative hypothesis invokes the binding of CPPs 
to negatively charged lipids and disruption of the bilayer structure by formation of 
inverted micelles resulting in their traversing into the cytoplasm [17]. Translocation may 
either involve entrapment of the peptide within the micelle and release on the other side of 
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the plasma membrane, or formation of micelles locally perturbs the bilayer and thereby 
induces the insertion of the peptide into the bilayer and the membrane transfer (Figure 
1.2).  
 
Figure 1.2: Translocation mediated by the formation of inverted micelles. In the model (a), the 
peptides are entrapped in micelles, which can release them inside the cell. In the model (b), the micelles 
perturb the structure of the bilayer, allowing peptide translocation. (Figure taken from [17]). 
               
                                                                                                             
Thirdly, a translocation similar to the action of antibiotic peptides has been suggested for 
CPPs [18]; [19]; [20]. The classical models that describe the transport of antimicrobial 
peptides across biomembranes are the toroidal pore, barrel-stave model and the carpet 
model [21], [6], [22]  (Figure 1.3). Almost all antimicrobial peptides are organized into an 
amphipathic structure composed of hydrophilic and hydrophobic aminoacids [23]. The 
peptides reach the membrane either as monomers or oligomers and then bind to the 
surface of the membrane with their hydrophobic surfaces facing the membrane and their 
hydrophilic surfaces facing the solvent. In the pores model a limited number of peptides 
first assemble on the lipid bilayer and then inserts into the bilayer with the hydrophilic 
regions of the peptides associating with the phospholipid head groups while the 
hydrophobic regions associate with the lipid core, and when a threshold concentration of 
peptide is reached, transient pores can be formed (Figure 1.3(a)).  
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Figure 1.3: Models proposed for the membrane permeation of membrane-active antimicrobial 
peptides: (a) toroidal pore model, (b) barrel-stave model, and (c) carpet model. Color designation: blue, 
hydrophobic surface; red, hydrophilic surface. Figure modified from [22]  
 
 
In the barrel-stave model (Figure 1.3(b)), the peptides insert in a perpendicular 
orientation to the plane of the bilayer, forming the “staves” in a “barrel”-shaped cluster, 
with the hydrophilic regions of the peptides facing the lumen of the pore and the 
hydrophobic regions interacting with the lipid bilayer. In the carpet model, peptides 
accumulate on the membrane surface until the membrane is disintegrated (Figure 1.3 (c)). 
The real mechanisms behind passive translocation of the CPPs are still mostly unknown, 
although it is clear that the attractive peptide–membrane interactions are important for the 
internalization process. 
 
 
1.1.  TAT peptide 
 
In 1988, during the research in the field of AIDS, the remarkable ability to traverse a cell 
plasma membrane of a protein involved in the replication of HIV-1 was revealed [24], 
[25]. Later it was shown that the minimal length required for the biological cell-
penetration of this molecule was much shorter. The TAT regulatory protein is an 86-
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amino-acid-long nuclear protein, of which the 48–57 aminoacid residues (Gly-Arg-Lys-
Lys-Arg-Arg-Gln-Arg-Arg-Arg), designated as HIV1 TAT peptide (Figure 1.4), are 
responsible for translocating across the cell plasma membrane [26], [27], [28]. Thus TAT 
became known as the first cell-penetrating peptide.  
 
         
           Figure 1.4: Secondary structure of TAT 
peptide. Illustration was prepared with the 
software MolMol 
(http://ftp.mol.biol.ethz.ch/software/MOLMOL/) 
 
 
 
The HIV1 TAT peptide can provide a powerful tool for biologically active molecule 
delivery [29]. Its cell membrane penetration capacity was applied to transport 
fluorophores, nucleotides, proteins [30], drugs, supermagnetic nanoparticles [31], imaging 
and radiotherapeutic agents [32] and genes into cells [33], [16]. Proteins with a mass 
exceeding 100 kDa, 40 nm magnetic nanoparticles, quantum dots [34], [35] and even 200 
nm liposomes [36], [37], [38] have been delivered to the cellular interior using TAT 
peptides [39]; [40]. The TAT-CPP contains 10 amino acids comprising six arginine and 
two lysine residues making the peptide highly cationic. It has been shown that the amount 
and rate of cellular uptake strongly depends on the component number of basic residues, 
specifically the number of arginines [41]; [42]. Also, substitution of a non-charged 
glutamine residue with alanine has no effect on cellular uptake, but substitution of any of 
the basic residues (arginine or lysine) significantly decreases cellular uptake.  
 
 
 1. Introduction and general objectives 
 
 16
1.1.1. Active mechanism of TAT peptide 
 
In spite of the fact that up to now the TAT peptide was under intense investigation, the 
exact internalization mode, intracellular routing and destination are still controversial. It is 
now accepted that the entry to cells by an endocytotic mechanism is achieved by 
macropinocytosis, caveolae-mediated and clathrin dependent endocytosis. 
An evidence for a macropinocytotic mechanism of TAT uptake in live mouse cells was 
published in 2004 and shown by co-localization of an endosome marker with TAT [43]. 
Latter, experiments with methyl-βcyclodextrin, which is used as an inhibitor of lipid raft 
formation, suggested that internalization of fluorescently labelled TAT peptide is mediated 
by lipid raft dependent macropinocytosis in Namalwa cells [10]. They showed that TAT-
fusion proteins (30 kDa) entered cells by macropinocytosis, too.  In addition, early studies 
using a caveolae-mediated endocytosis inhibitor failed to inhibit TAT internalization [44]. 
Caveolin-dependent endocytosis in HeLa and HL3T1 cells was shown for TAT-avidin and 
fusion protein of TAT with enhanced green fluorescent protein (EGFP) [8]. In HeLa, 
HepG2 and CHO cells, the internalization of fluorescently labelled TAT peptide was 
suggested to result from clathrin dependent endocytosis [45], [46].  
In 2007 was observed that TAT and other arginine-rich CPPs were internalized by means 
of all three endocytotic pathways, depending on peptide concentration [12]. 
Chlorpromazine (CPZ) was used for the inhibition of clathrin mediated internalization, 5-
(N-ethyl-N-isopropyl) amiloride (EIPA) for inhibition of macropinocytosis and methyl-β-
cyclodextrin (MβCD) for disruption of import through caveolae/lipid rafts. At low 
concentrations below 10 µM TAT entered through caveolae/lipid-raft-mediated 
endocytosis and macropinocytosis. Interestingly, at higher peptide concentrations, clathrin 
mediated internalization was more probable. 
 
 
1.1.2. Internalization of cargoes conjugated to TAT peptide 
 
The uptake mechanisms identified for TAT alone retain their validity also for cargoes that 
are introduced into the cells through coupling to the peptide. Tünnemann et al. [29] 
showed that TAT carries cargoes across cell membranes with high efficiency by at least 
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two functionally distinct mechanisms according to whether the cargo is big or small. Big 
cargoes, such as proteins or quantum dots, enter via caveolae endocytosis and 
macropinocytosis. Small cargoes, such as peptides of less than 30–40 amino acids, enter 
both slowly by endocytosis and rapidly by an unknown mechanism, called transduction, 
that utilises the membrane potential [29], [17], [47].  
 
 
1.1.3. Independence of receptor mediated uptake 
 
Although there were some early reports indicating the existence of specific cell surface 
receptors for the TAT protein [48], experiments with L- and D-enantiomeric peptides [42], 
[49] do not support the idea of CPPs binding to specific receptors. Instead, in some cases, 
the initial association with the plasma membrane was attributed to multivalent interactions 
with cell surface heparan sulphate proteoglycans. Contrary to the uptake through 
endocytosis, for a fluorescein-labelled TAT peptide, Ziegler et al. [50] observed a rapid 
cellular import into fibroblasts that was heparan sulphate dependent. Other studies [12]  
showed that at low peptide concentrations (1 µM) removal of cell surface heparin 
sulphates had no effect on TAT peptide uptake but for 100 µM, a requirement for cell 
surface heparan sulphate for peptide internalization was necessary. 
 
 
1.1.4. Non –endocytotic uptake of TAT peptide  
 
Recently, systems genetically modified to inhibit the endocytotic uptake were used to 
clarify the role of endocytosis in the translocation of TAT peptide [51]. The potential side 
effects and lack of specificity of inhibitors for endocytosis made the previous studies 
difficult to interpret. For example, methyl-β-cyclodextrin affects both lipid raft [10] and 
caveolin-coated vesicle formation. Hence it is difficult to distinguish between 
macropinocytosis and caveolin-dependent endocytosis. Also, the inhibitors could have 
other side effects that may influence the import of TAT, e.g. chlorpromazine was shown to 
interface with a number of Ca2+-dependent signalling pathways [52]. Thus, genetically 
modified systems or physical methods seem to be more promising to clarify the 
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translocation mechanism of TAT because they avoid possible side effects of chemical 
inhibitors for endocytosis. The results with such systems demonstrated that the 
transduction of TAT into living cells is not dependent on any endocytic or pinocytic 
events and most importantly, TAT was not excluded from cells that were transferred to 4 
°C, a state where all potential endocytic pathways are inhibited [51]. 
To elucidate the non-endocytic entry routes and the transduction mechanism, one 
possibility is the study of TAT peptide interaction with model membrane systems. In all 
models the first step for the translocation is the association of the peptide with components 
of the outer membrane leaflet. It is generally agreed that electrostatic forces between the 
positively charged peptide TAT and negative charges of phospholipids play a major role 
in the membrane binding of the peptide [53]. In addition, non-electrostatic forces, such as 
hydrogen bonding and hydrophobic or van der Waals forces, support the contact of TAT 
with the membrane by contributing about ~20% to the binding energy [54]. Recent results 
showed that the efficient binding of TAT requires a fluid membrane with lipids in the 
liquid-disordered state for the peptide-induced selective segregation of the negatively 
charged lipids, which is necessary to neutralize the positive charges on the peptide [53], 
[55]. Also, the interaction between TAT peptide and the membrane remains unaffected by 
changing the chemical nature of the negative charge, such as replacing PG with PS, but it 
is attenuated in the presence of a high salt concentration [54].  
There are experimental reports that indicate that TAT peptides labelled by fluorophores 
can directly traverse the lipid bilayers of giant unilamellar vesicles (GUVs) but not large 
unilamellar vesicles (LUVs) of the same composition [56]. Besides the size, the 
composition of the membrane seems to play an important role in TAT peptide 
translocation. Mishra and al. [19] showed internalization of the peptide in GUVs 
(diameters of 5–30 µm) with high content of DOPE (40%). They observed also from 
SAXS experiments that the cationic CPP interacts strongly with localized negative charges 
in both anionic and neutral zwitterionic lipids (DOPS and DOPC) but does not interact 
directly with DOPE. Besides that, SAXS pointed to a pore formation mechanism similar 
to the antibiotic peptides. On the other hand, the pore mechanism was also suggested by 
molecular dynamics simulation [18] and black lipids experiments [20]. But the results of 
[51] argue against the formation of nonselective pores in membranes of genetically 
modified cells to suppress endocytosis. The authors observed that the fluorophore FITC 
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applied to the cells together with the TAT peptide, remained outside of the cells, whereas 
TAT transduced selectively into the cells. 
In any case, a consensus regarding the uptake mode has not been reached. Despite the 
controversy and uncertainty regarding the uptake mechanism, the property of TAT to 
deliver nonpermeable molecules into living cells makes it an attractive tool for biological 
sciences as well as medicine and biotechnology. It is therefore essential to identify 
precisely the criteria which can define an efficient cell penetration with a high degree of 
cargo transfer. 
 
 
1.2. Antimicrobial peptides  
 
Bacterial resistance to conventional antibiotics has become a major problem worldwide 
due to their extensive use. There are already strains of bacteria resistant to all available 
drugs [57]. The development of new families of antibiotics that can overcome the 
resistance problem has become a very important task.  
Antimicrobial peptides are an abundant and diverse group of molecules (see 
http://www.bbcm.univ.trieste.it/~tossi/pag1.htm for database) that are produced by many 
tissues and cell types in a variety of invertebrate, plant and animal species to defend 
themselves against invading pathogenic microorganisms [23], [22]. The peptides differ in 
size, sequence, charge, hydrophobicity and their ability to interact with membranes. But 
they all are amphipathic, charged molecules which can kill bacteria and fungi. The 
following four features are required of antimicrobial peptides [58]: 
(1) Selective toxicity; the peptides should discriminate between host and microbial cells.  
(2) Fast killing; the time needed for bacterial killing should be much shorter than the 
doubling time of the target bacteria, which is 20 min in the case of Escherichia coli.  
(3) Broad antimicrobial spectra; desirably a single peptide species should be effective 
against many species of microorganisms. 
 (4) No resistance development; the peptide should have such a mechanism of action that 
the bacteria cannot easily develop resistance against it.  
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The killing mechanism of antimicrobial peptides is different from that of conventional 
antibiotics, so antimicrobial peptides are considered as attractive substitute for additional 
drugs. However, most antimicrobial peptides are toxic not only to a variety of 
microorganisms, but also to healthy cells [59].  
Their aminoacid composition, amphipathicity, cationic charge and size influence the 
attachment of the antimicrobial peptides and insertion into membrane bilayers. 
Subsequently these peptides contact the anionic surface of the cytoplasmic membrane and 
insert initially in the interface of the hydrophilic head groups of membrane phospholipids. 
After insertion into the membrane, antimicrobial peptides act by either disrupting the 
physical integrity of the bilayer, or via membrane thinning, to form pores by “carpet”, 
“barrel-stave” or “toroidal-pore” mechanisms.  
 
 
1.2.1. The antibacterial peptide NK-2 
 
The peptide NK-2 is derived from the natural occurring 78 amino acid residue protein 
NK-lysin, isolated from porcine small intestine [60]. Investigations on a broader selection 
of bacteria, fungi and mammalian cells showed a high selectivity against pathogens and 
NK-2 was suggested to be a potent member of peptide antibiotics [60]. Also, it is not toxic 
for human cells. The NK-2 peptide is mainly unstructured in phosphate buffer but adopts 
an amphipathic, α-helical secondary structure in membranes and it interacts specifically 
with negatively charged lipids. The α-helical structure of NK-2 was confirmed by circular 
dichroism (CD) and Fourier transformed infrared spectroscopy (FTIR) measurements 
[61].  
All antimicrobial peptides investigated in this study are derived from NK-2 (Table 1.1). 
The first modification of NK-2 is the substitution of the aminoacid cysteine by a serine 
(NK-CS) to inhibit the dimerisation of NK-2 by disulfide bridges. This substitution is 
expected to improve the stability by reducing the peptide sensitivity to oxidation. The 
replacement also leads to a significant increase of the antibacterial activity of the peptide 
NKCS against both Gram negative and Gram positive bacteria [62]. Figure 1.5 shows the 
secondary structure of NKCS. 
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Table 1.1: Comparison of the amino acid sequences of the antibiotic peptides NK-2 and 3 
derivatives used in this study. The modified amino acids are highlighted in red. 
 
39 40 41 42 43 44  45 46 47 48 49 50  51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 
K I  L R G V C K K I M R T F L R R  I S  K D I L T G K K 
K I  L R G V S  K K I M R T F L R R  I S  K D I L T G K K 
                                                      L R R  I S  K D I L T G K K 
                                                      L R G  I S  K K I D R T L K      
 
NK-2 
NK-CS 
NKCS-[15-27] 
NKCS-[15-27S] 
  
 
To study the partial activity of the NK-CS peptide and to determine the function and the 
importance of different sections of the peptide, short derivatives were analysed: NKCS-
[15-27] and NKCS-[15-27S]. Figure 1.6 shows the structure of NKCS-[15-27], which is 
similar to NKCS-[15-27S]. The properties of NKCS and its derivatives are summarized in 
Table 1.2. 
 
         
 
 
Figure 1.5: The secondary structure of NKCS with two α–helices (prepared with the software 
MolMol). The hydrophobic face is shown in yellow. 
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Figure 1.6:  The secondary structure of NKCS-
[15-27] (prepared with the software MolMol). 
The hydrophobic face is shown in yellow. 
 
 
    
Table 1.2: Properties of the peptides as determined by the calculator based on Hoop-Woods scale 
from http://www.innovagen.se/custom-peptide-synthesis/peptide-property-calculator.asp 
 
Peptide Mass (Da) Net charge Hydrophobicity Iso-electric point, pI 
NKCS 3186 +10 6.76 12.4 
NKCS-[15-27] 1527.9 +5 4.36 11.6 
NKCS-[15-27S] 1527.9 +5 4.36 11.6 
                  
 
 
 
 
 
1.3. Biological and model lipid membranes 
1.3.1. Evolving membrane models 
 
 
The cell is the fundamental unit in biology. Each cell is spatially defined by its 
cytoplasmic membrane which acts as a protective wall to exclude most molecules that are 
not actively imported by living cells. This is an efficient way for a cell to prevent 
uncontrolled influx or efflux of solutes, which otherwise could be harmful to it. Lipids are 
a fundamental part of all cellular membranes, organized in bilayer form. Most membranes 
contain around 40% lipids, the internal mitochondrial membrane around 20% only, and 
the myelinic membranes even up to 70% lipids [63]. 
The bilayer nature of biomembranes was first suggested in 1925 by Gorter and Grendel 
[64] and an important step forward was the fluid mosaic model by Singer and Nicholson 
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in 1972 [65]. According to this model, the cell membrane was characterized as: “a two-
dimensional oriented solution of integral proteins (or lipoproteins) in the viscous 
phospholipids bilayer solvent” [65]. 
The modern view for molecular architecture of cell membrane is a composite model. The 
first shell is a multi-component lipid-protein bilayer called plasma membrane, followed on 
the cytoplasmatic side, by a two-dimensional macromolecular network called membrane 
cytoskeleton (Figure 1.7). The extra-cellular side of plasma membrane is covered by a 
densely packed macromolecular film formed by the head groups of cell surface 
glycoproteins. The membrane-associated cytoskeleton is a rubber-like network composed 
of semi-flexible spectrin interconnected with actin filaments [66]. 
 
 
 
Figure 1.7: A schematic representation of plasma membrane (modified from [66]) 
 
 
 
The eukaryotic lipid membrane is unique in its great diversity of lipid species. The three 
main lipid constituents of the cellular membrane are phospholipids, cholesterol, and 
glycolipids (Table 1.3) [67]. The major structural lipids in eukaryotic membranes are the 
phospholipids (Figure 1.8): phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidic acid (PA). A typical 
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phospholipid consists of four components: fatty acid(s) which contains saturated or cis-
unsaturated acyl chains of varying lengths, the platform to which the fatty acids are 
attached (glycerol), a phosphate, and an alcohol attached to the phosphate [63] which 
determines the name of the hydrophilic head group. In glycerophospholipids, the fatty acid 
in sn-1 position of the glycerol backbone is usually saturated and the fatty acid in sn-2 
position unsaturated. Phosphatidylcholine accounts for >50% of the phospholipids in most 
eukaryotic membranes. 
 
Table 1.3: Approximate lipid composition of different cell membranes, [67]  
 
 
Glycolipids are derived from sphingosine. Instead of phosphoryl choline, glycolipids 
contain one or more sugars attached to the primary hydroxyl group of the sphingosine 
backbone. The major sphingolipids in mammalian cells are sphingomyelin (SM) and the 
glycosphingolipids (GSLs), which contain mono-, di- or oligosaccharides based on 
glucosylceramide and sometimes galactosylceramide.  
The third major constituent of the eukaryotic biomembranes is cholesterol, accounting up 
to 30-50 mol % of the total lipids in plasma membrane. It has a tetracyclic ring structure 
with a double bond in one of the rings and one free hydroxyl group (Figure 1.8).  
The distribution of lipids between intra- and extracellular leaflets of the plasma membrane 
is asymmetric and maintained by ATP-dependent systems [68]. For instance, PE and the 
negatively charged phospholipid PS are mainly located in the intracellular leaflet of the 
bilayer, making the membrane electrically polarized. In contrast, PC and SM reside 
predominantly in the outer leaflet [69]. Glycolipids are oriented with the sugar residues on 
Percentage of total lipid by weight 
 
 
Lipid 
Liver cell 
plasma 
membrane 
Erythrocyte 
plasma 
membrane 
Myelin 
 
Mithocondrion 
(inner and outer 
membrane) 
Endoplasmatic 
reticulum 
E. coli 
 
Cholesterol 
Phosphatidylethanolamine 
Phosphatidylserine 
Phosphatidylcholine 
Sphingomyelin 
Glicolipids 
Others 
17 
7 
4 
24 
19 
7 
22 
23 
18 
7 
17 
18 
3 
13 
22 
15 
9 
10 
8 
28 
8 
3 
35 
2 
39 
0 
(trace) 
21 
6 
17 
5 
40 
5 
(trace) 
27 
0 
70 
(trace) 
0 
0 
0 
30 
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the extracellular side of the membrane [70]. The distribution of cholesterol may also be 
asymmetric between the cytoplasmic and ectoplasmic leaflets [71]. 
 
 
 
Figure 1.8: Examples of membrane lipids, (a) DPPC, (b) DOPC, (c) DPPS, (d) DOPS, (e) DPPE, 
(f) DOPE and (g) cholesterol (structural formulas from http://avantilipids.com) 
 
 
Lipid packing into small scale 3D structures is governed by the effective shape of the lipid 
that is determined by van der Waals volume and geometry of the molecule as well as 
hydration shell, conformation, intermolecular forces acting on a molecule or electrostatic 
interactions. The final shape of a lipid aggregate is generally described by the so-called 
shape factor or packing parameter p defined as [72] 
al
vp = ,  
where v is the volume of hydrocarbon chain(s), a is area occupied by the headgroup, and l 
the maximum length of hydrocarbon chains.  
The simplest lipid structures are spherical micelles, formed by molecules preferentially 
adopting conical shape, i.e. p < 1/3 (Figure 1.9). Non-spherical (e.g. rod-like or discoidal) 
micelles are possible when molecular geometry of molecules resembles to a truncated 
cone with 1/3 < p < 1/2. The biologically most important mode of lipid packing requires 
nearly cylindrical molecular shape with 1/2 < p < 1 for lipids. In this case a bilayer is 
formed. In a planar bilayer, the hydorophobic chains in the middle of the structure are very 
well accommodated as they are in a hydrophobic environment and the hydrophilic heads 
are exposed to water. But at the edge, the hydrocarbon chains are exposed to water and the 
structure will tend to shield them by connecting open edges with each other. This will 
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result in vesicles (Figure 1.10) and the lipid bilayer is thus held together efficiently by 
non-covalent interaction. When p > 1 inverted structures with a negative spontaneous 
curvature (e.g. inverted micelles or inverted hexagonal phase) are favoured (Figure 1.9). 
 
 
 
Figure 1.9: Schematic illustration of the impact of packing parameter p on lipid aggregate 
structures 
 
 
 
Membrane curvature plays an important role in cellular function. The proper function of 
neurons, for example, requires both the highly curved synaptic vesicles of the axons and 
the more planar plasma membrane [63]. The bilayer-forming lipids have a spontaneous 
curvature close to zero (Figure 1.9), whereas the curvature of the non-bilayer forming ones 
may be either positive or negative [72]. A significant fraction of eukaryote cell lipids are 
non-bilayer forming [73]. These lipids may facilitate fusion and transport by increasing 
membrane flexibility. Membrane curvature also affects the penetration and activity of 
certain membrane-bound enzymes [74]; [75].  
 
 
 1. Introduction and general objectives 
 
 27
 
       
            Figure 1.10: Lipid structures. Figure 
modified from 
http://www.pharmainfo.net/reviews/overview-
brain-targeting-drug-delivery-system 
 
 
 
Phosphatidylcholine (PC) and phosphatidylserine (PS) have a nearly cylindrical molecular 
geometry, with the lipidic tails facing each other and the polar headgroups interfacing with 
the aqueous phase. Phosphatidylethanolamine (PE) assumes a conical molecular geometry 
because of the relatively small size of its polar headgroup (Figures 1.8 and 1.9). The 
inclusion of phosphatidylethanolamine in phosphatidylcholine bilayers imposes a 
curvature stress onto the membrane, which is used for budding, fission and fusion [76].  
Sphingolipids have saturated (or trans-unsaturated) tails so they are able to form taller, 
narrower cylinders than phosphatidylcholine lipids of the same chain length and they pack 
more tightly, adopting the solid “gel” phase; they are fluidized by sterols. 
 
 
 
1.3.2. Bacterial membranes 
 
The cell membranes of bacteria (Gram positive and Gram negative) differ in their 
composition significantly from mammalian cell membranes (see Table 1.3). Gram positive 
bacteria like Bacillus subtilis or Staphylococcus carnosus possess only one lipid bilayer 
connected to a peptidoglycan network, but Gram negative bacteria like Escherichia coli 
have a second lipid bilayer consisting of lipopolysaccharide reaching into the extracellular 
space [77]. The lipopolysaccharides (LPS) are relevant in bacterial infections. When LPS 
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is released from the membrane it can cause sepsis depending on the location and 
eliberated amounts. In consequence a potent antimicrobial peptide should inhibit the 
release of LPS by Gram negative bacteria, either by killing the bacteria very fast before 
the LPS is secreted or by neutralizing the bacterial endotoxin after its release [78].  
Bacterial plasma membranes mainly consist of phosphoethanolamine (PE) and a high 
amount of anionic lipids like phosphatidylglycerol (PG) (see Table 1.3 for E. coli).  
 
 
1.3.3. Membrane dynamics and physical properties 
 
According to the solid-liquid composite model [66] the lipid matrix of cell membranes is a 
fluid structure at physiological temperature. The membrane lateral pressure profile is an 
essential concept of lipid dynamics. This is in part determined by the repulsive 
interactions between the hydrated headgroups and in the acyl-chain region of the bilayer, 
leading to a tendency for lateral expansion. Conformational, translational, and vibrational 
membrane dynamics take place on various time- and length-scales. In addition, several 
factors affect lipid dynamics: temperature, hydration, pressure, as well as the structure and 
number of lipid species involved [79].  
Techniques that offer insight into structure and diffusion processes in cellular membranes 
include fluorescence recovery after photobleaching (FRAP) [80], single particle tracking 
(SPT) [81], fluorescence correlation spectroscopy (FCS) [82], fluorescence resonance 
energy transfer (FRET) [83] and nuclear magnetic resonance (NMR), infrared and Raman 
spectroscopy, electron paramagnetic resonance (EPR) on spin labels, differential scanning 
calorimetry (DSC), X-ray and neutron diffraction and molecular simulations [84], [85].   
Lipids can adopt a variety of phases and the phase transition (Figure 1.11) is mostly 
thermally induced. In the gel phase (Lβ), the hydrocarbon chains are ordered in all-trans 
configurations and there is a long-range translational order, impeding lateral movement. 
Increasing of the temperature above the melting point, Tm, result the liquid-crystalline 
phase (Lα). This is characterized by low conformational order in the carbon chains (lower 
internal order) and by low translational order (lower packing order, higher translational 
diffusion). For this reason this state has also been termed liquid-disordered phase (Ld). 
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Figure 1.11: Lipid bilayer phases: (a) liquid-crystalline or liquid-disordered, (b) solid gel, (c) 
liquid-ordered. Representation modified from [63] 
 
 
The steroid structure of cholesterol molecule is rather stiff and smooth favouring a gel-like 
ordered conformation of vicinal lipid acyl chains, but on the other hand its molecular 
shape is clearly different from other lipids thus disrupting the packing order of 
neighbouring phospholipids. As a consequence, to accommodate better into phospholipid 
bilayer cholesterol induces a so-called liquid-ordered (Lo) phase which is an 
intermediate between Lβ and Lα phases (Figure 1.11) demonstrating rapid lateral diffusion 
of lipids similar to fluid bilayers and conformational order of acyl chains resembling that 
of gel phase membranes [86], [63]. Furthermore, incorporation of cholesterol into 
phospholipid membranes increases the thickness of bilayers, reduces its elasticity and the 
permeability to small water-soluble molecules [87]. Without cholesterol -such as in 
bacteria- a cell would need a cell wall. Cholesterol prevents crystallization of 
hydrocarbons and phase shifts in the membrane. The affinity of cholesterol for membrane 
lipids varies significantly with the polar headgroup and backbone structure of the lipid 
molecule, generally decreasing in the order SM>PS>PC>PE [88], [89]. 
 
 
1.3.4. Membrane proteins 
 
Membrane proteins are long-chained polypeptide polymers consisting of amino acid 
residues [72]. Compared to membrane lipids, membrane proteins are structurally rigid. 
Membrane proteins can be divided into two classes: integral proteins and peripheral 
proteins. The integral proteins penetrate the bilayer and can be directly integrated into the 
membrane by exposure of hydrophobic aminoacid residues, either in a transmembrane 
 1. Introduction and general objectives 
 
 30
manner (single pass α-helix, multi pass α-helices, β-barrel) or by embedding of a α-helix 
only in the cytosolic leaflet, i.e. in plane with the membrane. Their functional domains 
may be located within the hydrophilic head group or within the hydrophobic core. 
Examples of the former class are cell adhesion molecules, and of the second ion pumps, 
hormone receptors, photosynthetic reaction centres or enzymes generating extracellular 
matrix proteins such as hyaluronic acid synthase [66]. 
Peripheral proteins are associated with membranes indirectly by lipidic anchors, i.e. fatty 
acids (myristic acid, palmitic acid), prenyl groups (farnesyl, geranylgeranyl) or a C-
terminally linked glycolipid (glycosylphosphatidylinositol-(GPI)-anchor). Examples 
include many receptors, and proteins involved in membrane based signal transduction 
processes, such as phospholipases or GTPases [66]. A second major coupling mechanism 
is through electrostatic interaction. A peculiar mode of binding is through amphiphatic α-
helices, which exhibit a hydrophobic and hydrophilic face in the axial direction. They can 
switch between a horizontal and a normal position by charging the hydrophilic ends. The 
transition between membrane and cytoplasmic proteins is not very distinct. Thus, proteins 
involved in formation of coats such as clathrin and caveolin may also be considered as 
membrane associated proteins. 
 
 
 
1.3.5. Model membranes 
 
Because of the high complexity of natural biomembranes, simplified model membranes 
are used to characterize properties of lipids, their supramolecular aggregates or their 
interaction with a broad variety of peptides. Liposomes are artificial lipid vesicles 
composed of concentric lipid bilayers that enclose an intravesicular water compartment. 
These model membranes were first produced in 1965 by Bangham and co-workers [90]. 
When exposed to water, bilayer-forming lipids spontaneously form multilamellar bilayers 
with diameter varying from 200 nm to several microns. Multilamellar vesicles (MLVs) are 
heterogeneous both in size and shape and thus are undesirable for many applications. 
Generally more homogenous liposome populations are achieved by exposing the lipid 
dispersion to either ultrasonication so as to obtain small unilamellar vesicles (SUVs, 
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diameters < 50 nm) or extrusion through polycarbonate filters with small pores to produce 
large unilamellar vesicles (LUVs), with diameters approx. 50-200 nm depending on the 
filter pore diameter . 
Eukaryotic cells have typically diameters of approximately 10-100 µm being much larger 
than SUVs or LUVs. Size difference may cause misinterpretations in experiments, which 
are sensitive to membrane curvature and lipid packing conditions. From this point of view, 
the giant unilamellar vesicles (GUVs), prepared by electroformation [91] or by solid 
hydration method [92], with diameters from 5 to 200 µm represent more cytomimetic 
model system [93], [94].  
 
 
1.3.5.1. Giant unilamellar vesicles (GUVs) 
 
Giant unilamellar vesicles (GUVs) have been extensively used in recent years as model 
systems to study, e.g., the lateral structure and mechanical properties of membranes, 
considering the effect of lipid-lipid, lipid-DNA, lipid-peptide and lipid-protein 
interactions. GUVs have the advantage of being geometrically analogue to living cells, 
due to their size of a few tens of micrometers [94]. Due to the possibility of visualizing 
single GUV, the problem of shape and size heterogeneity and the presence of 
multilamellar vesicles are excluded. Because of their similarity to cells, they are used to 
study mechanical and elastically properties of membranes [95]. GUVs can also be used as 
micro reactors; for instance, by the microinjection technique, targeted enzymatic-catalyzed 
reactions can take place inside the vesicles [96].  
GUVs are also applied in medicine and physiology, to study muscular activity, by building 
GUVs from muscle tissue membranes, and monitoring the activity of glucose transporters. 
Also, signal transduction pathways and the influence of toxins could be studied with the 
aid of GUVs. Native membranes can build GUVs too, e.g. pulmonary surfactants [97].  
Several preparation methods for GUVs have been tested over the years: freeze-thawing 
and dehydration-rehydration of small vesicles followed by fusion in bigger vesicles or the 
largely applied electroformation method [92]. In all cases the lipid film is swollen in an 
aqueous environment (Figure 1.12).  In the electroformation method a low-voltage electric 
field can induce lipid swelling and liposome formation. The disadvantage of this method 
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is the fact that the yield of GUVs and their size decrease strongly when ions (salt) are 
present in the aqueous solution. 
 
 
Figure 1.12: Principle of lipid swelling (taken from www.avantlipids.com) 
 
 
The mechanism of GUVs electroformation is not totally clarified, although several effects 
of the external electric field on lipid swelling and vesicle formation have been suggested. 
The diameter of the electroformed GUVs highly depends on the lipid composition, 
swelling medium and the external AC field parameters (0.2-10 V), which give the 
amplitude of the electro-osmotic vibration and subsequently the membrane tension of a 
GUV immediately upon its formation [98]. For example, for POPC/cholesterol, the 
optimal conditions for the formation of GUVs were 1.5 V at 10 Hz. In addition, presence 
of more than 50 mol % cholesterol drastically inhibits the formation of GUVs [98].  The 
addition of high salt concentrations strongly reduces the formation of giant vesicles. In 
case of LiCl, NaCl, or KCl, the limiting concentration seems to be 10 mM, while the 
maximal concentrations for MgCl2, CoCl2, and CaCl2 are 1.7, 1.0, and 0.2 mM, 
respectively [99]. The predominating mechanism of electroformation is most likely the 
electro-osmotic periodic movement of the water medium at the water-electrode interface. 
These vibrations are directed perpendicularly to the electrode surface, where the initial 
lipid film is deposited. The vibrations pull lipid lamellae off the electrode causing their 
separation and growth (Figure 1.12). At this stage the contact area is increased, and 
destabilizing due to the AC-field through electro osmotic vibrations takes place. Thus, the 
neighbour vesicles fuse together into larger ones [97], become spherical and within a few 
minutes some of them will eventually separate from the electrode. 
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1.4. Motivation of the study  
 
TAT peptide is a promising tool for biological sciences, medicine and technology due to 
its attractive property to deliver cargoes molecules into living cells. Hence, it is important 
to clarify the mechanism of membrane translocation in order to control and develop this 
property. 
The starting point and the motivation for the present study rely on the controversy 
regarding the possible mechanisms of TAT peptide internalization. Descriptions of the 
internalization process vary from energy-independent cell penetration of membranes to 
endocytic uptake: clathrin-independent endocytosis [7], caveolae-mediated endocytosis 
[9] or macropinocytosis [10]. Regarding the passive translocation, three mechanisms were 
suggested for charged peptides to cross the hydrophobic barrier of a biological membrane 
without utilizing an active transport system. One possibility is direct membrane 
penetration. An alternative hypothesis is the binding of TAT to negatively charged lipids 
and disruption of the bilayer structure by formation of inverted micelles resulting in their 
traversing into the cytoplasm [17]. Thirdly, a translocation similar to the action of 
antibiotic peptides has been suggested for TAT: the toroidal pore, barrel-stave model or 
the carpet model [21], [6], [22]. Experiments with genetically modified systems to 
suppress the endocytic internalization demonstrated that the transduction of TAT into 
living cells is not dependent on any endocytic or pinocytic events. Also, TAT was not 
excluded from cells that were transferred to 4 °C, a state where all possible endocytic 
pathways are inhibited. Recently, a pore formation, similar to the antibiotic peptides, was 
suggested by molecular dynamics simulations and black lipid experiments for TAT 
peptides. 
In any case, a consensus regarding the uptake mode has not been reached. Therefore, the 
present study attempted to identify the factors defining an efficient membrane penetration 
and thus to elucidate the passive mechanism of TAT peptides translocation.  
The interaction of the peptide with membranes was studied previously with different 
techniques [100]. Circular dichroism (CD), Fourier transform infrared spectroscopy 
(FTIR) or nuclear magnetic resonance (NMR) were applied to identify the secondary 
structure of the peptides in membranes. Mass spectrometry was used to observe the non-
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covalent complexes between lipids and peptides or proteins. Atomic force microscopy 
(AFM) allows the observation of nanometre-sized particles and provides information on 
the topological organization of lipids membrane after peptide addition. 
Electrophysiological measurements offer information about the ability of CPPs to induce 
pore formation when incorporated into lipid bilayes. Also fluorescence measurements as 
fluorescence transfer and quenching were used to find information on the positioning of 
the fluorophore within the hydrophobic phase of the membrane bilayer [100]. 
 In spite of the fact that numerous studies exist on the structures which are adopted by 
peptides in solution and in or at membranes, not much is known about their mobility on or 
within membranes. This thesis applies for the first time single molecule tracking using 
high-speed video fluorescence microscopy to analyse TAT dynamics on well defined 
membrane model systems. Obviously, cell membranes and GUVs are systems very 
different, but the experiments in this thesis attempt to create a model system with 
biological relevance. Mammalian cell membranes are comprised mainly from PC, PE, PS 
and cholesterol, so the same phospholipids were chosen for the GUVs composition. At the 
same time, the system was kept as simple as possible to answer specific questions 
concerning the basic principles of peptide-membrane interaction and translocation 
mechanism of TAT peptide through the membranes. 
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2. Materials and Methods  
 
2.1. Peptides 
Probe Company 
Biotin-Ahx-YGRKKRRQRRR 
molecular mass, 1.87 kDa 
Peptide Specialty Laboratories GmbH  
(Heidelberg, Germany) 
5,6-TAMRA-RRRQRRKKRG 
molecular mass, 1.81 kDa 
Peptide Specialty Laboratories GmbH  
(Heidelberg, Germany) 
Alexa Fluor 647-RRRQRRKKRG 
molecular mass 2.2 kDa 
Peptide Specialty Laboratories GmbH  
(Heidelberg, Germany) 
KILRGVSKKIMRTFLRRISKDILTGKK-C 
(Dy647-ME)-NH2, molecular mass 4.05 kDa 
Biosyntan (Berlin, Germany). 
LRRISKDILTGKK-C(Dy647-ME)-NH2 
molecular mass 2.4 kDa 
Biosyntan (Berlin, Germany) 
LRGISKKIDRTLK-C(Dy647-ME)-NH2 
molecular mass 2.4 kDa 
Biosyntan (Berlin, Germany). 
Purity of TAT peptides > 97%; Purity of NKCS peptides > 95% 
 
 
2.2. Lipids 
The phospholipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, 1,2-dioleoyl-sn-glycero-
3-phosphocholine, 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine, 1,2-dioleoyl-sn-
glycero-3-phospho-L-serine, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, 1,2-
dipalmitoleoyl-sn-glycero-3-phosphoethanolamine, 1-palmitoyl-2-oleoyl-sn-gylcero-3-
phosphoethanolamine, 1-palmitoyl-2-oleoyl -sn-glycero-3-[phospho-rac-(1-glycerol)]  and 
cholesterol were purchased from Sigma-Aldrich (Germany). 
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2.3. Fluorescent tracers 
Probe Company 
TR-DHPE  Invitrogen GmbH ( Karlsruhe, Germany) 
DiI-C18 Sigma-Aldrich (Schnelldorf, Germany) 
Bodipy-PC Invitrogen GmbH ( Karlsruhe, Germany) 
FITC-dextran,  
molecular mass, 4 kDa and 40 kDa 
Invitrogen GmbH ( Karlsruhe, Germany) 
Lucifer Yellow 
molecular mass, 386 Da 
Invitrogen GmbH ( Karlsruhe, Germany) 
Alexa Fluor 488-maleimide 
molecular mass 643 Da 
Invitrogen GmbH ( Karlsruhe, Germany) 
Alexa Fluor 546 
molecular mass, 1.08 kDa 
Invitrogen GmbH ( Karlsruhe, Germany) 
Alexa Fluor 647-maleimide 
molecular mass, 1.3 kDa 
Invitrogen GmbH ( Karlsruhe, Germany) 
Dextrans  
molecular mass, 3 kDa and 70 kDa 
Invitrogen GmbH ( Karlsruhe, Germany) 
 
 
2.4. Chemicals 
 
The sugars glucose and sucrose were purchased from Sigma-Aldrich (Schnelldorf, 
Germany). The salts sodium chloride (>99% purity), calcium chloride, calcium carbonate 
and magnesium chloride, were obtained from Carl Roth (Karlsruhe, Germany) and PBS 
from Biochrom AG (Berlin, Germany). The solvents chloroform and methanol were 
purchased from Merck (Darmstadt, Germany) and from Acros Organics (United 
Kingdom) respectively. 
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2.5. Electroformation of giant unilamellar vesicles 
 
In this study, GUVs were created by electroformation according to [91], [94]. All 
phospholipids were dissolved in chloroform or chloroform/ methanol 2:1 at a 
concentration of 1.27 mM. The lipids were mixed in different compositions and ratios to 
obtain GUVs with different properties (see Results for mixtures details).  20 µl of the 
respective lipid mixture dissolved in chloroform (or chloroform/methanol) were deposited 
on an indium tin oxide (ITO) coated cover slip (from SPI Supplies, West Chester, PA, 
USA), which was then dried in a desiccator under vacuum. The dried lipid film was 
swollen with 235 µl of 250 mM sucrose in bidestilled water and then covered with a 
second ITO cover slide. The latter was fixed on a rubber ring at a distance of 2 mm from 
the first one, thus creating a chamber (Figure 2.1).  
 
 
    
      Figure 2.1: A cartoon of the 
electroformation chamber: 
a. copper conductive tape 
b. ITO coated slides 
c. rubber ring 
d. lipid film 
e. DIC image of GUVs. 
 Scale bar, 20 µm 
Details are given in the text. 
 
 
For efflux experiments, the glucose solution from the electroformation chamber was 
mixed with fluorescent tracers in a concentration of 5-10 µM. 
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For electroformation of GUVs an alternating voltage of 1.2 V at 12 Hz provided by a 
pulse generator was applied for 2.5 h across the chamber. Then, the voltage was raised to 
1.8 V for 30 min to detach the giant vesicles from the glass slides. 100 µl of vesicles in the 
bulk volume were transferred with a pipette in the measurements chamber, a MatTek dish 
containing 300 µl of 250 mM glucose solution. The density difference between the outside 
(glucose) and the inside (sucrose) of the vesicles caused their sedimentation allowing their 
optical analysis using an inverted light microscope. Addition of 0.1 mol % of the 
fluorescent lipid analogs DiI-C18 or Bodipy-PC to the lipid mixture before swelling 
allowed an observation of the vesicle formation by confocal laser scanning microscope. In 
case of lipid mixtures with different phases, as expected confocal imaging (Figure 2.2) of 
GUVs revealed a domain structure [101], because both Bodipy-PC and DiI-C18 
preferentially localized in DOPC-rich liquid-disordered lipid domains [102]. 
 
     A.  
           
 B.   
          
          
 Figure 2.2: Confocal images of GUVs labelled by Bodipy-PC 
(A) Confocal imaging of lipid domains in a GUV prepared from lipid mixture DOPC/DPPC/chol. Bodipy-
PC was used as marker for unsaturated lipid chains; therefore, the bright domains correspond to those 
comprising mostly DOPC. (B) GUV prepared from lipid mixture DOPC/DPPE/chol labelled with Bodipy-
PC. The thin dark stripes correspond to DPPE rich domains. 
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2.6. Confocal fluorescence microscopy 
 
Confocal microscopes are integrated electronic systems, in which the light microscope is 
part of the imaging system containing a photon detector or camera, a computer and 
computer software, and electronic devices for image display, printing and storage. Epi-
illumination is used, so for sample illumination and fluorescence detection, the light 
follows the same optical path through the objective lens. This means that the objective 
lens function as both condenser and objective.  The optical principle of the method is 
presented in Figure 2.3. A laser provides a light beam that scans the specimen from top to 
bottom in a pattern called raster.  
 
 
        Figure 2.3: Principle of 
confocal microscopy, picture 
taken from http://www.zeiss.de 
 
  
The fluorescence emitted by the specimen is separated from the incident light by a 
dichroic mirror and focused by the tube lens through a pinhole on a photomultiplier tube 
(PMT) [103]. A confocal image is not generated in the microscope but it is built up 
electronically, point by point and over time, from fluorescent signals received by the PMT 
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and accumulated in the image memory board of the computer [104].  Fluctuations in light 
intensity are converted into a continuously changing voltage (an analogue signal) by the 
PMT detector. The analogue signal is then digitized in pixels which are stored in an image 
frame. The computer holds the image in an image memory board until it is processed and 
displayed on a computer monitor. The major advantage of this technique is that 
fluorescence from out-of-focus planes above and below the specimen is blocked and does 
not contribute to the final image. This effect is due to pinhole configuration in the focal 
plane.  
The quality of a confocal image is determined by four principal factors: spatial resolution, 
resolution of light intensity, signal-to-noise ratio and temporal resolution. Spatial 
resolution describes the smallest resolvable distance between two points in the image 
plane and along the z-axis. It depends on the pinhole aperture, the zoom factor, and the 
scan rate which are adjusted using the software. Resolution of light intensity is defined as 
the number of grey levels that are assigned to an image and can be controlled by adjusting 
the photon signal using the electronic gain and offset controls of the PMT. Signal-to-noise 
ratio defines the degree of image visibility or clarity and is determined mainly by the 
intensity of the object and background.  Image brightness is affected by laser power, 
fluorochrome density in the specimen, numerical aperture (NA) of objective lens, confocal 
zoom factor, raster scan rate and fluorescence filters. Temporal resolution depends on the 
raster scan rate, processing rates of the detector, the analogue-to-digital converter and the 
computer [104]. 
One of the main features of confocal microscope is the ability to produce thin (0.5 to 1.5 
micrometers) optical sections through fluorescent specimens [105]. Thus, by moving the 
specimen up and down, a 3D image can be recorded. Image information is restricted to a 
well-defined plane and the contrast is dramatically improved due to the reduction of 
background fluorescence. Furthermore, optical sectioning eliminates artefacts that occur 
during physical sectioning and fluorescent staining of tissue specimens for traditional 
forms of microscopy.  
The non-invasive confocal optical sectioning technique enables the examination of both 
living and fixed specimens under a variety of conditions with enhanced clarity. However, 
it should be noted that, because confocal microscopy collects only a fraction of the total 
fluorescence emitted by a sample, the excitation energy required to image this 
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fluorescence must be higher than in conventional fluorescence microscopy. Therefore, the 
amount of photobleaching per detected photon is higher. Photobleaching should be 
minimized by using stable fluorophores and by operating the confocal microscope at low 
laser power, high detector sensitivity, and maximum objective numerical aperture. 
Confocal fluorescence microscopy has been widely used in cell biology; single living cells 
and cellular processes can be studied by this technique, e.g. for visualization of organelles, 
distribution of electrical potential, pH imaging, calcium imaging, etc. [106]. 
In this study, GUV formation and peptide binding to GUVs were examined by a confocal 
laser scanning microscope (LSM 510 Meta from Carl Zeiss, Jena, Germany) equipped 
with a water immersion plan apochromat 63X objective lens (NA 1.2) at room 
temperature. DiI-C18, TR-DHPE and R-TAT were excited with the 543 nm line of a He-
Ne laser, while AF-TAT was excited using a red He-Ne laser emitting at 633 nm. For 
detection of AF 488 or fluorescein, the 488-nm line of an argon ion laser was directed 
over an HFT UV/488 beam splitter, and fluorescence was detected with a BP 505–550 
band pass filter. For the simultaneous detection of fluorescein-labelled dextran molecules 
and Alexa Fluor 647 labelled peptides, the 488 nm light of an argon ion laser and the light 
of a 647 nm He-Ne laser were directed over an HFT UV/488/543/633 beam splitter, and 
fluorescence was detected using an NFT 545 beam splitter in combination with a BP 505–
530 band pass filter for fluorescein detection and an LP 650 long pass filter for Alexa 
Fluor 647 detection. 
 
 
2.7. Single molecule microscopy 
 
The first single particle tracking (SPT) experiments were done on cell membranes [107] 
and devices for the detection and observation of signals emitted by single dye molecules 
have been developed in the last 20 years. In SPT, computer-enhanced video microscopy is 
used to track the motion of proteins, peptides or lipids on the membrane surface. Active 
transport in living cells occurs at the speed of several micrometers per second, Brownian 
motion of cell components ranges from diffusion constants of ~100 µm2/s for proteins in 
solution, over ~1 µm2/s for lipids in bilayers, to values smaller than 10-4 µm2/s for 
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immobilized membrane proteins [108]. In most cases, a millisecond time-resolution is 
required to resolve sub-micrometer displacements. In single molecule fluorescence 
microscopy (SMF) the achievable localisation precision depends only on the signal-to-
noise ratio (SNR) and the stability of the optical setup in our case being between 20 and 
40 nm [109]. 
Central component of the custom-built microscope set-up used in this thesis is a 
conventional wide-field epifluorescence microscope from Zeiss (Axiovert 200TV, Carl 
Zeiss, Jena, Germany, Figure 2.4). The illumination is achieved by three lasers: a Sapphire 
100 DPSS-laser with 488 nm (Coherent, Santa Clara, CA, USA), a frequency doubled Nd-
YAG laser and a HeNe-Laser emitting at 532 and 635 nm, respectively and their beams 
are coupled into an optical mono-mode fibre (Pointsource, Hamble, UK) after passage 
through an acoustic-optical tuneable filter (AA Opto-Electronic, Orsay, France) [109].  
 
 
Figure 2.4: Setup for single molecule fluorescence microscope [109] 
 
 
A high pressure HBO lamp can be used for illumination of the complete field of view. The 
emitted fluorescence light is separated from the excitation light by a triple dichromatic 
beam splitter, which reflects the three excitation lines onto the sample, while the three 
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fluorescence bands are transmitted to the detection system via three Notch filters 
extincting remaining excitation light (Semrock, Rochester, NY, USA) [109]. An iXon BI 
DV-860 (Andor Technology, Belfast, Northern Ireland) electronmultiplying CCD camera 
is used for image acquisition with a pixel size of 24 x 24 μm2. The microscope is equipped 
with a 63X NA 1.2 water immersion objective lens in combination with a 4X magnifier in 
front of the camera. The pixel size is 95.2 nm and the total observation field has a size of 
(12.2 μm)2. Laser illumination can be adjusted so the bleaching of the sample is minimised 
with a custom-built, programmable electronic counter, which allows modulating the laser 
power via the AOTF driver. In our experiments fluorescence was excited with laser light 
(irradiance of 0.5 kW/cm2), which was coupled into the epi-illumination light path of the 
microscope by an optical monomode fibber. 
Single fluorescently labelled molecules can be imaged microscopically as diffraction-
limited spots. Their intensity distribution can be approximated by a two-dimensional 
Gaussian function [110], [111]. Thus, the localization of the very centre of the Gaussian 
corresponding to fluorescent molecule position can be determined with high precision by a 
fitting process (Figure 2.5). In this way, the localization precision may reach a few 
nanometres under optimal conditions. Thereby, fluorescence microscopy allows us to 
follow the traces of single molecules in time with a very high spatial precision.  
The technique has mostly been applied in analyzing the movement of single receptors and 
lipid molecules in biological membranes ([108], [81]). It was recently extended to study 
single-molecule mobility within solution and the interior of mammalian cells, like 
nucleocytoplasmic transport of single fluorescent cargo molecules or the mobility of 
specific intranuclear proteins [111].  
In contrast to conventional techniques applied to study molecular mobility such as 
fluorescence correlation spectroscopy (FCS) or fluorescence recovery after 
photobleaching (FRAP) techniques, SMF microscopy can well discriminate multiple 
forms of mobility in heterogeneous systems. For high single molecule detection, the 
reduction of background fluorescence, optimisation of light transmission in the 
microscope, and high-speed CCD camera systems for signal detection in combination with 
digital image processing are required [109]. 
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Figure 2.5: Nanolocalization of single molecules:  (A) Image of single surface-attached fluorescence 
labelled Oyster 565 protein molecules, image size 10.8 x 10.8 μm2. (B) The surface plot of 2D-Gaussian 
corresponding to intensity distribution (greyed image, below) localise the centre of mass with a precision 
(orange arrows) significantly smaller than the half-width of the diffraction limited spot size (yellow arrows), 
[112] 
 
 
The aim of SPT experiments was to follow the single molecule trajectories of lipid tracer 
molecules (DiI-C18 and TR-DHPE), and labelled TAT and NKCS peptides in order to find 
their diffusion coefficients. All the experiments were performed at room temperature. For 
R-TAT and AF-TAT peptide analysis a single frame integration time of 10 ms at a frame 
rate of 100 Hz was used, whereas an integration time of 33 ms at a frame rate of 30 Hz 
was used for lipid tracers and Dy-NKCS imaging. All single-molecule tracking 
experiments were performed on the top surface of freshly prepared GUVs. To adjust the 
correct focal plane the radius of the GUV at the equatorial level was measured employing 
DIC and a grid with known dimensions within the eyepiece. Then, the focus was shifted 
with a distance corresponding to the GUV radius to reach the top plane of the spherical 
GUV. Only on top surface single molecule signals could be observed using fluorescence 
mode. In solution the particles have a very high diffusion which can not be detected by the 
camera.  Since the radius of the GUVs was at least 20 µm, the curvature of the surface was 
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small enough to allow the imaging of an extended region of top GUV. The axial resolution 
was about 1 µm. The circular region on the GUV top starts from a diameter of about 14 
µm, so larger that the observation field (12.2 μm). From this field usually 1000-2000 
single frames were recorded in a single movie. For each experimental situation a total of 
three independent experiments comprising 10-15 movies were obtained and the trajectory 
data were pooled. 
 
 
2.7.1.  Trajectory analysis 
 
A major advantage of SPT is the ability to sort the trajectories into various modes of 
motion of individual molecules. Diffusion coefficients depend on size and shape of 
molecules, their interaction with the medium (solvent) and the viscosity of medium. The 
mean square displacement (MSD) is a measure of the averaged distance that a molecule 
travels. A linear relationship between MSD and time indicates free Brownian motion. In 
most cases motion in the biological membranes is not limited to pure diffusion. That is 
due to domain and possibly rafts formation. So, anomalous or confined diffusion to the 
point of immobile fractions are also observed (Figure 2.6). In this case, MSD dependence 
on time is characterized by a sublinear increase. FRAP experiments on phospholipids 
membrane revealed anomalous diffusion and for two components, mobile and immobile 
fractions were identified [81]. The lipids diffusion in GUVs depends strongly on 
membrane composition and FCS was used to evaluate the role of cholesterol in changing 
the lipid mobility in raft-like domains [113], [102]. 
In this thesis single molecule signals from individual frames were identified and tracked 
with Diatrack 3.02 (Semasopht, Chavannes, Switzerland). This is a commercial image 
processing program for the localization of single objects and construction of their 
trajectories. All further data processing was performed with ImageJ [114] and Origin 8.0 
(OriginLab Corp., Northampton, MA, USA. 
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Figure 2.6: MSD as a function of time t for simultaneous diffusion and flow, pure diffusion, diffusion in the 
presence of obstacles, and confined motion (modified from [108]) 
 
 
Each single-molecule trajectory was defined by coordinates (xi, yi). The running frame 
number was denoted by i, where 1 ≤ i ≤ N and N stands for the number of frames in which 
the molecule was observed. For each trajectory the squared displacements r2(n tc ) were 
computed with tc representing the imaging cycle time (inverse frame rate), and n the 
difference of the running index. Therefore, n tc  was the time between two observations of 
the same molecule. By averaging the square displacements for identical values n tc  the 
mean square displacements (MSD), r2(n tc )   were obtained. 
 For two-dimensional Brownian motion the MSD is given by: 
r2(n tc ) = 4D(n tc )  (1) 
Plotting MSD against time, the diffusion coefficients can be derived from single molecule 
trajectories, if they are long enough to generate significant mean values. Generally, the 
MSD values of many different trajectories were averaged for identical values of n tc  to 
improve statistics. When the population contains different mobility fractions, a joint 
analysis of the trajectories according to Eq. 1 is not suitable and a jump distance analysis 
is more appropriate. 
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2.7.2. Jump distance analysis 
 
The jump distance analysis is a method adequate to analyse heterogeneous populations. 
When a particle starts at a given position, the probability that it will be encountered in a 
distance r within a shell of width dr from the start position at time t is given by: 
p(r,t) dr = 1
4πDt e
−r 2 / 4 Dt 2π r dr    (2) 
Eq. 2  is valid for a single particle species diffusing in two dimensions [115]. 
Experimentally, this probability distribution function can be approximated by a frequency 
distribution, quantifying the jump distances within respective intervals [r, r+dr] travelled 
by single particles after n tc . When several particle subspecies with different mobilities are 
present or particles change their diffusion speed during their trajectory, the jump distance 
distributions cannot be described by eq. 2 with a single diffusion coefficient. However, 
such particle populations can be analysed by curve fitting using more than one term 
according to eq. (3). A jump distance distribution containing contributions from two 
different subspecies is described by, 
′ p (r,t) dr = M f j
2Dj t
e−r
2 / 4 D j t r dr
j=1
2∑  (3), 
where M is the total number of jumps considered in the analysis, and f1 and f2 denote the 
relative fractions with diffusion constants D1 and D2, respectively.  
In this study, in analysed jump distributions the distances between molecular positions in 
successive frames were evaluated. 
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2.8. Sample preparation for light microscopy 
 
To study mobility of lipids in the bilayer, GUVs labelled with TR-DHPE or DiI-C18 at 10-7 
mol % were diluted (1:4) in the experimental chamber (MatTek dish) containing glucose 
or glucose/NaCl solution. To verify the changes induced by peptides the labelled GUVs 
were added in a glucose or glucose/NaCl solution containing B-TAT or unlabelled NKCS. 
For measurements focusing on the interaction of TAT or NKCS with the GUVs, the 
glucose or glucose/NaCl solutions were mixed with the peptides before adding the GUVs. 
Fluorescent R-TAT or AF-TAT was used at a concentration of 250 pM, or at a 
concentration of 100 pM in a mixture with unlabelled B-TAT at a total concentration 2 
µM. Dy-NKCS peptides were used at a concentration of 500 pM for single molecule 
experiments. The freshly prepared GUVs in glucose solution were added with a pipette in 
the experimental chamber. The sample chamber had a total volume of 400 µl, and the final 
molar ratio of lipids to peptides in the experiment with 2 µM was 27.5/1. In the 
experiments using 250 pM TAT the respective molar ratio was 220000/1. For 500 pM the 
molar ratio NKCS/lipids is 1/110000. Incubation time of GUVs in the peptide-glucose 
solution before image acquisition was 30 min. 
For the efflux experiments, GUVs loaded with fluorescent tracers were diluted 1:10 in 
glucose solution and 100 µl from the final dilution were added in the MatTek dish 
containing peptides solution. In case of tracers influx experiments, the dyes were mixed 
together with the peptide in glucose or glucose/NaCl solution. 
 
 
2.9. Monte Carlo simulations 
 
Computer simulation has become an established method of research in science and a 
useful tool in complementing both analytical theory and experiment. Monte Carlo is a 
computational model used for simulation of atomic and molecular assemblies. In our study 
this method is applied to analyse the interaction between peptides and lipid membranes 
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[116]. Typically, the Monte Carlo methods are based on reduced representation of the 
peptide-membrane system, in contrast to the all-atom representation used in molecular 
dynamics simulations. The reduced representation enables comprehensive sampling of 
peptide conformations and locations in the membrane in an accelerated manner. 
The Monte Carlo simulations were performed with the help of Yana Gofman from GKSS 
Research Center, Geesthacht, Germany. The used model assumes that the hydrocarbon 
region of the membrane bilayer is represented as a smooth hydrophobic profile of 40 Å 
width (Figure 2.7). For anionic membranes, a negative surface charge, representing the 
molecular fraction of PS, is located on both sides of the membrane at a distance of 15 Å 
from the midplane, corresponding to the location of the lipid phosphate groups. 
The peptide structure is taken from Protein Data Bank (PDB) and it is represented by two 
interaction sites (α-carbon atom and side chain interaction centre) based on specific 
structure and energy characteristic of the aminoacids [117]. 
The total free energy of membrane association (ΔGtotal) is calculated as the difference 
between the free energies of a peptide in the aqueous phase and in the membrane, using 
the following equation [116]: 
 
ΔGtotal = ΔGcon + ΔGsol + ΔGimm + ΔGlip + ΔGdef + ΔGcoul                (4), where 
 
ΔGcon is the change in the free energy due to membrane-induced conformational changes, 
 ΔGsol is the free energy of transfer of the peptide from the aqueous environment to the 
membrane,  
ΔGimm represents the immobilization of the peptide in the membrane, 
ΔGlip is the free energy due to the change in the conformational freedom of the lipid 
chains, 
ΔGdef accounts for the membrane deformation associated with peptide incorporation into 
the membrane, 
ΔGcoul is the Coulombic attraction between charged amino acids and the (negative) 
membrane surface charge. 
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Figure 2.7: The model of membrane structure employed in Monte Carlo simulations 
 
 
ΔGcon can be decomposed into contribution from short- and long-range interactions and 
can be calculated (in kT units) as   
 
k
S
kT
H
kT
G conconcon Δ−Δ=Δ               (5), 
where ΔHcon and ΔScon are the enthalpy and the entropy changes associated with the 
transition of the peptide from the aqueous phase into the lipid bilayer, k is the Botzamann 
constant, and T is the simulation temperature [117]. 
ΔGcon, ΔGsol,  ΔGimm are calculated based on a hydrophobicity scale [117], which includes 
free-energy contribution from peptide solvation, immobilization and perturbation effects.  
ΔGdef results from compression or expansion of the lipids chains after insertion of the 
peptide into lipid bilayer. The ΔGdef value is calculated based on a statistical-
thermodynamic molecular model of the lipid chains and fitted a harmonic potential: 
2
0 )( zzG mdef −=Δ ω          (6), 
where zm and z0 are the actual and native widths of a monolayer, ω is a harmonic force 
constant related to membrane elasticity. In this case it is z0 = 20 Å, according to the model 
and ω = 0.22 kT/ Å2 [117]. 
The Coulombic interactions between the peptide and the membrane are calculated using 
the Gouy-Chapman theory that describes the electrostatic potential in the aqueous phase 
near the membrane. 
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It should be noted that the Monte Carlo computational model has inherent limitations due 
to its simplification of the peptide-membrane interaction. First, the model treats the 
interaction of a single peptide molecule with the lipid bilayer and is not suitable in this 
form to study peptide concentration effects. Second, the model membrane is planar and 
membrane curvature effects, which are anticipated in the presence of e.g. PE lipids, cannot 
be simulated. Third, the model describing both the peptide and membrane is simplified to 
a representation computationally accomplishable. Also, it does not allow studies of 
specific peptide-lipid interactions in atomic details. Hydrogen bonds and salt bridges 
between the peptide and lipid, as well as the exact stereochemistry of the interaction, are 
not taken into account explicitly. 
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3. Results and discussion 
 
The experimental results providing the framework of this thesis are divided in two 
intertwining parts. The first part analyses the direct interaction between TAT peptide and 
lipids and therefore the experiments were performed in sucrose/glucose solution with all 
ions excluded from the medium. Mammalian cell membranes are composed mainly from 
PC, PE, PS and cholesterol [70], so the same phospholipids were chosen for the GUV 
composition. At the same time, the system was kept as simple as possible to find specific 
answers concerning the basic principles of peptide-membrane interaction and the 
translocation mechanism of the TAT peptide through the membranes. Considering the 
physiological relevance of salt ions, the second part of the thesis is focused on the 
influence of different ions on TAT translocation efficiency. 
 The literature suggested and also our findings pointed to a pore formation mechanism for 
TAT, similar to antimicrobial peptides. Therefore, an additional study on the interaction of 
antimicrobial peptide NKCS with GUVs is included, too. 
 
 
 
3.1. TAT peptide interaction with neutral and anionic 
membranes 
 
 
To study gradually the effect of TAT peptide on model membranes of different 
compositions, we started with GUVs comprising neutral PC with saturated or unsaturated 
chains and anionic comprising PC/chol and a low content of PS (15 %). 
 
 
3.1.1.  Imaging and tracking of single lipid analogs within 
anionic and neutral GUVs 
 
In order to obtain a reference for the measurements on neutral and anionic membranes, the 
dynamics of the chosen model bilayer systems was studied. For that, the lipid mobility in 
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GUVs of different lipid compositions was measured. Lipid diffusion in model membranes 
can well be analysed by imaging and tracking single dye-coupled lipid analogs [118], 
[119]. The fluorescent TR-DHPE and DiI-C18 were used as tracer molecules. Six 
different sets of experiments were performed using liquid-ordered GUVs formed by DPPC 
and cholesterol (SN), liquid-disordered GUVs formed by DOPC and cholesterol (UN), and 
GUVs formed by equimolar ternary mixtures of DOPC, DPPC and cholesterol (MN). In 
addition to these mixtures of neutral components we examined anionic GUVs created by 
inclusion of 15 mol % DOPS or DPPS (indicated by the subscript “A” instead of “N”, see 
Table 3.1). The cholesterol was added to better mimic mammalian cell membranes. 
Besides that, it contributes to a clearer distribution of the domains in GUVs [102]. 
Furthermore, incorporation of cholesterol into phospholipid membranes increases the 
thickness of a bilayer, reduces its elasticity, and diminishes the permeability to small 
water-soluble molecules [87]. Anyway, it was shown that cholesterol could induce 
modifications in physical properties of the membrane [120]. Therefore incorporation of 
cholesterol would mimic better the biomembranes. 
 
Table 3.1: Composition of giant unilamellar vesicles (GUVs). The designation of the respective 
lipid composition is given in the first column 
 
 
Lipid Molar Ratio 
 
 
GUVs 
DPPC DOPC Chol DPPS DOPS 
 
SN 0.5 - 0.5 - - 
 
MN 0.33 0.33 0.33 - - 
 
UN - 0.5 0.5 - - 
 
SA 0.425 - 0.425 0.15 - 
 
MA 0.283 0.283 0.283 0.15 - 
 
UA - 0.425 0.425 - 0.15 
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The tracer molecules were added at a ratio of 10-7 mol % to the lipids mixture before 
preparation of the GUVs. After electroformation, 100 µl of the vesicles were transferred to 
the microscope sample chamber containing glucose solution 250 mM. Single diffraction-
limited spots of fluorescence could be observed in the single-molecule microscope, when 
the focal plane was adjusted to the GUVs top. Movies comprising 1000 frames were taken 
at a frame rate of 30 Hz. A sequence of successive movie frames is shown in Figure 3.1, 
which illustrates the motions of several single lipid tracer molecules within the GUV 
membrane. In 3.1(A) nine subsequent movie frames illustrate the motions of four single 
TR-DHPE molecules (marked by arrows) in a total time of 300 ms in the two-component 
GUVs (DOPC, DPPC and cholesterol at a molar ratio of 0.33/0.33/0.33). The field of view 
of a single frame was (12.2 µm)2, and contained the upper plane of a single GUV. In (B) 
are presented the trajectories of two-dimensional diffusion of the same four particles in 
GUVs membrane as determined by the tracking software. The shown area corresponds to 
the microscopic field of view. 
 
 
 Figure 3.1: Single TR-DHPE molecules diffusing within the GUV membrane [121]. 
 
The mobility of the DHPE-TR and DiI-C18 tracer molecules within the model bilayers 
were analysed by quantifying the single molecule mean square displacements (MSD) as a 
function of time according to eq. 1 from chapter 2.7.1. A linear fit to the MSD values 
yielded the average diffusion coefficients of the tracer molecules in the respective GUV 
membrane (see Figure 3.2.A). As expected, the lipid analogs diffused faster within GUVs 
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known to have a disordered phase (D= 2.7 ± 0.05 µm2/s) compared to GUVs known to 
comprise an ordered phase (D= 0.6 ± 0.02 µm2/s). The diffusion of TR-DHPE in the MN 
GUVs yielded an intermediate value of D= 1.0 ± 0.03 µm2/s. All results were summarized 
in Table 3.2.  
 
 
Figure 3.2: TR-DHPE diffusion on neutral and anionic GUVs  
(A) MSDs of TR-DHPE molecules plotted as a function of time for neutral membranes: (▲) data from 
GUVs created by DPPC/cholesterol, SN; (■) DPPC/DOPC/cholesterol, MN; (●) DOPC/cholesterol, UN. (B) 
MSDs of TR-DHPE plotted as a function of time for anionic membranes: (▲) data for GUVs generated 
from DPPC/cholesterol/DPPS, SA; (■) DPPC/DOPC/cholesterol/DPPS, MA; (●) DOPC/cholesterol/DOPS, 
UN. 
 
Table 3.2: TR-DHPE mobility within GUVs 
Sample DMSD 
[µm2/s] 
D1,SPT 
[µm2/s] 
Fraction 
1 
D2,SPT 
[µm2/s] 
Fraction 
2 
SN 0.6±0.02 0.66±0.02 1 - - 
MN 1.0±0.03 0.70±0.02 0.82 2.55±0.07 0.18 
UN 2.7±0.05 2.53±0.05 1 - - 
SA 0.49±0.03 0.55±0.01 1 - - 
MA 1.43±0.07 0.87±0.06 0.64 2.48±0.04 0.36 
UA 2.90±0.11 2.54±0.05 1 - - 
 
Similar values for the diffusion coefficients in liquid-ordered and liquid-disordered 
GUVs were obtained with the tracer DiI-C18. The results are presented in Table 3.3. 
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Table 3.3: DiI-C18 mobility within GUVs 
Sample DMSD 
[µm2/s] 
D1,SPT 
[µm2/s] 
Fraction 
1 
D2,SPT 
[µm2/s] 
Fraction 
2 
SN 0.5±0.02 0.44±0.01 1 - - 
MN 1.4±0.05 0.60±0.02 0.4 1.83±0.05 0.6 
UN 2.1±0.03 1.84±0.03 1 - - 
SA 0.65±0.01 0.50±0.02 1 - - 
MA 2.85±0.02 0.64±0.02 0.3 2.44±0.03 0.7 
UA 2.98±0.05 1.88±0.05 1 - - 
 
 
However, confocal analysis of GUVs with mixed lipids suggested a phase separation of 
the ordered and disordered domains (see Figure 2.2 for a MA GUV from chapter 2). In this 
case the lipid dynamic is not properly described by one component and two different 
diffusion coefficients are expected.  
In an MSD analysis molecules with distinct mobility cannot be differentiated, but this can 
be achieved by a so-called jump distance analysis. In this analysis the jumps performed by 
a molecule from frame to frame are evaluated. The distribution of jump distances follows 
a "stretched" Gaussian distribution according to eq. 2 (see chapter 2.7.1) for a single 
diffusive species. Figures 3.3 (A) and (C) show the jump distance distributions for the 
neutral liquid-ordered and -disordered single component GUVs, respectively. The 
distributions could well be described by eq. 2, and yielded comparable diffusion 
coefficients as the MSD analysis for single species (see Table 3.2). However, for the jump 
distance distribution of the neutral MN GUV a fit according to eq. 2 did not match the 
data. If differently mobile molecules or molecules with different mobility in domains with 
distinct viscosity occur, more than one expression according to eq. 2 must be evaluated. In 
the case of the MN GUVs we yielded an excellent description of the data with two 
diffusion terms according to eq. 3 (Figure 3.3 (B)). 
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Figure 3.3: Analysis of TR-DHPE diffusion on neutral and anionic GUVs [121] (A, B and C) Jump 
distance analysis for TR-DHPE in neutral GUVs. (D, E and F) Jump distance analysis for TR-DHPE in 
anionic GUVs.  
 
As suggested by the confocal analysis of the mixed GUVs it could be concluded that TR-
DHPE and DiI-C18 were moving in two different spatially separate domains exhibiting 
different viscosities corresponding to two diffusion coefficients. These were D1= 0.70 ± 
0.02 µm2/s and D2= 2.55 ± 0.07 µm2/s, respectively, for TR-DHPE. Since about 80% of 
the jumps were observed in the more viscous liquid-ordered and only about 20% were 
observed in the more liquid-disordered domain, one can assume that TR-DHPE localizes 
preferentially in the liquid-ordered lipid domain [102]. By comparing the two diffusion 
constants determined in the MN GUVs to the results of the single component GUVs, one 
can conclude that tracer diffusions were observed in the two spatially separated liquid-
ordered and liquid-disordered lipid phases. This was in good agreement with the results of 
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[101], which detected micron-scale coexisting liquid phases in GUVs. Unfortunately, it 
was not possible to visualize the domain structure microscopically in the GUVs used 
below for single-molecule imaging of TAT peptides, because of a significant spectral 
overlap of the available dyes for marking the domains and the spectrum of the employed 
fluorescent tracer molecule.  
Following the analysis of lipid tracer mobility in neutral GUVs comparable measurements 
were performed for anionic GUVs. We imaged TR-DHPE and DiI-C18 within anionic 
liquid-ordered (SA) and liquid-disordered (UA) two-component GUVs, as well as anionic 
four components GUVs (MA). We found that the presence of 15 mol % of the charged 
lipid did neither change the phase behaviour nor the lipid tracer mobility considerably 
compared to neutral GUVs (see Figure 3.3 (D-F), and Table 3.2). Also in this case, TR-
DHPE diffuse faster within GUVs with an unordered phase with a diffusion coefficient of 
D= 2.54 ± 0.05 µm2/s compared to GUVs, which exhibit an ordered phase, D= 0.55 ± 0.02 
µm2/s.  The small changes observed compared to neutral GUVs were probably due to the 
fact that the cholesterol mole fraction was altered to a minor extent [102]. 
The similar results obtained with two different lipid tracers, TR-DHPE and DiI-C18 led to 
the conclusion that the lipid model system is stable and well described.  
 
 
3.1.2.  Confocal imaging of TAT peptide-GUVs interaction 
 
To analyse the general aspects of TAT peptide’s interaction with the model membranes, 
we incubated pre-formed GUVs with peptide/glucose solution, in different concentration 
of TAT. These samples were observed by confocal laser scanning microscopy for 
extended periods of time.  
For anionic GUVs, R-TAT fluorescence at the GUV surface strongly increased upon 
incubation with 1 µM peptide within 30 min. After 5 min a distinct labelling of anionic 
GUVs by R-TAT already could be recognized. Figure 3.4 shows images of exemplary MA 
GUVs at time points of 5, 15 and 30 min. In order to simplify the detection of the GUVs 
Figure 3.4 (A) displays images obtained with DIC. Figure 3.4 (B) shows the sample in the 
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rhodamine fluorescence channel. R-TAT does not translocate the MA GUVs, but just 
accumulates on the GUV membranes. Similar results were obtained for AF-TAT and 
GUVs made from all lipid mixtures used in this study. 
A surface labelling due to TAT binding could also be observed for neutral GUVs, 
although the fluorescence intensity was clearly weaker. When the R-TAT concentration 
was increased to 2 µM, a distinct labelling of the GUVs was already clearly visible after 3 
min for anionic and neutral GUVs. Again the labelling of the anionic GUVs was stronger 
than that of the neutral GUVs. 2 µM TAT was a concentration well above the threshold 
found for the import of TAT into living cells [29]. 1 µM is the threshold for C2C12 
myoblast cells. However, we did not detect any R-TAT fluorescence within neutral or 
anionic GUVs in the glucose solution. Obviously, the peptides were not able to translocate 
across the membrane at concentrations up to 2 µM under the given experimental 
conditions. 
 
 
 
Figure 3.4: Time series of TAT peptide interaction with anionic GUVs in glucose  
(A) DIC images showing the MA GUVs; (B) Confocal fluorescence images of the GUVs incubated with 1 
µM R-TAT in the rhodamine channel. 
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3.1.3.  Lateral mobility of single TAT peptides on the GUV 
surface at low concentration 
 
In order to study mobility of TAT peptides on the membrane’s surface, we incubated 
neutral and anionic GUVs with 0.25 nM R-TAT. Single molecule imaging was started 
after 30 min incubation. The concentration of the R-TAT was so low that single 
diffraction-limited spots of R-TAT fluorescence became visible at the GUV surface, 
which could well be tracked resulting in trajectories of TAT peptides on the GUV surface. 
The small fluorescent spots displayed a higher mobility than the lipid tracers, so the 
imaging rate was increased from 30 Hz to 100 Hz to catch the fast motions without 
blurring the single molecule signals.  
 
 
 
         Figure 3.5: Single R-TAT peptide on 
the GUV surface [121] 
(A) sequence of six successive movie frames 
illustrating the motions of R-TAT; (B) plot 
of the corresponding two-dimensional 
diffusion trajectory of R-TAT molecule 
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Figure 3.5 (A) shows a sequence of six successive movie frames illustrating the motions 
of R-TAT over a time span of 0.51 s on anionic GUVs (DOPC/cholesterol/DOPS at a 
molar ratio of 0.425:0.425:0.15). Single frame integration time was 10 ms. Only every 10th 
image of the image sequence is presented. The field of view of a single frame was (12.2 
µm)2. In (B) is shown the plot of the corresponding complete two-dimensional diffusion 
trajectory of R-TAT molecule. 
To evaluate TAT peptide mobility on the GUV surface based on single particle tracking, 
out-of-focus signals were sorted out using a size threshold, which was set to restrict the 
analysis to diffraction limited signals only corresponding to single TAT peptide molecules 
in focus. As described above for lipid tracer mobility, a MSD and a jump distance analysis 
of R-TAT dynamics on the GUV surface was performed for the same lipid compositions. 
The results of this analysis are shown in Figures 3.6 and 3.7. Short trajectories are 
problematic for the MSD analysis, because only relatively few data points contribute to 
the calculation of the MSD at longer times causing strong data fluctuation. Therefore, only 
the first 5 time points were used to determine the diffusion constant corresponding to 
times up to 80 ms. 
 
 
Figure 3.6: Analysis of R-TAT diffusion on neutral and anionic GUVs at low concentration (0.25 
nM) (A) Plot of MSD versus time for of R-TAT on neutral membranes: (▲) represents GUVs made from 
DPPC/cholesterol (SN); (■) DPPC/DOPC/cholesterol (MN); (●) DOPC/cholesterol (UN); (B) Plot of MSD 
versus time for of R-TAT on anionic membranes: (▲) represents GUVs generated from 
DPPC/cholesterol/DPPS (SA); (■) DPPC/DOPC/cholesterol/DPPS (MA); (●) DOPC/cholesterol/DOPS (UN). 
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Table 3.4: R-TAT peptide mobility on GUVs  
 0.25 nM R-TAT 
0.1 nM R-TAT and 
2 µM B-TAT 
Sample 
DMSD 
[µm2/s] 
DSPT 
[µm2/s] 
DMSD 
[µm2/s] 
DSPT 
[µm2/s] 
SN 6.8±0.6 5.7±0.3 5.5±0.2 5.3±0.1 
MN 5.6±0.6 4.9±0.3 5.7±0.3 4.8±0.2 
UN 6.4±0.7 5.0±0.1 5.1±0.2 4.9±0.1 
SA 3.6±0.5 3.7±0.1 4.0±0.1 3.4±0.1 
MA 4.0±0.4 3.3±0.1 4.3±0.2 3.3±0.2 
UA 3.3±0.4 3.0±0.2 4.0±0.1 3.2±0.2 
 
 
The MSD plot and also the jump distance histogram clearly demonstrated a significantly 
higher mobility of the R-TAT than the membrane-embedded tracer molecules in all GUV 
systems examined (Fig. 3.6, 3.7 and Table 3.4). The mobility of the R-TAT peptide on the 
GUV surface was virtually identical for all examined GUV compositions within the 
precision of the measurements, and all jump distance histograms could well be fitted by a 
single diffusion component. This result was in agreement with the CLSM visualization of 
vesicle-attached R-TAT, which was uniform on GUVs made from MA and MN mixtures 
(Figure 3.8). 
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Figure 3.7: Analysis of R-TAT diffusion on neutral and anionic GUVs at low concentration (0.25 
nM) (A, B and C) Jump distance analysis for R-TAT in neutral GUVs for the different GUV compositions 
as indicated in the plots. (D, E and F) Jump distance analysis for R-TAT in anionic GUVs for the different 
GUV compositions as indicated in the plots [121]. 
 
 
 
         
       Figure 3.8 : Confocal images of GUVs 
labelled by R-TAT 
Incubation of MA GUVs with R-TAT in salt-
free medium yielded a uniform distribution of 
the peptide on GUVs, independent on lipid 
domains. 
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Obviously, TAT peptide mobility was independent of the lipid bilayer structure. A distinct 
difference, however, was observed for the mobility on neutral versus anionic GUVs. The 
diffusion coefficient of TAT on neutral GUV surfaces, DN,SPT =6.2±0.6 µm2/s, was 
significantly higher than on anionic GUVs, DA,SPT =3.5±0.5 µm2/s. This suggested a 
stronger interaction of the positively charged TAT peptide with anionic membranes. 
Also, the TAT peptide trajectories were considerably shorter than those of the lipid tracers 
in terms of the average number of frames, in which single molecules were observed 
sequentially. This indicated a rapid exchange of TAT peptides with the solution phase of 
neutral and anionic GUVs. The binding duration of the R-TAT molecules to neutral GUVs 
was shorter compared to anionic GUVs. We assume that this was due to an increased 
binding strength of the cationic TAT to the anionic GUVs in comparison to the neutral 
ones, which was already observed in the confocal microscope. Figure 3.9 shows the 
histograms quantifying the trajectory length of R-TAT molecules on neutral and anionic 
GUVs. The track length distributions showed a rapid decrease, which was approximately 
exponential. By fitting mono-exponential decay functions to these binding time 
distributions, we determined in the case of the neutral GUVs an average interaction 
duration of 13 milliseconds and 20 ms in case of the anionic GUVs.  
 
 
Figure 3.9: Distribution of the trajectory lengths [121] on neutral (A) and (B) anionic GUVs. 
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3.1.4.  Lateral mobility of single TAT on the GUV surface 
at high concentration 
 
The confocal experiments of R-TAT binding to GUVs revealed that at a concentration of 
at least 0.5 µM TAT peptides efficiently accumulate on the vesicle surface, especially in 
the case of anionic GUVs. In order to study the dynamics of TAT peptides within such a 
“peptide layer” we incubated the GUVs with to 2 µM non-fluorescent B-TAT 
supplemented with traces of R-TAT (0.1 nM) for 30 min prior to experiments. This 
guaranteed that even in the presence of a high overall TAT concentration single 
fluorescent TAT peptides would still be sparse enough to be discerned on the GUV 
surface with single molecule microscopy. As above, movies revealing single TAT peptide 
mobility on the GUV surface were acquired and their diffusion coefficients were analysed. 
We found that the mobility of R-TAT peptides on the GUV surface for all examined GUV 
compositions could well be fitted by a single diffusion component in jump distance 
histograms. The analysis revealed no reduction in the mobility of R-TAT in comparison to 
the low concentration situation (see Table 3.4), so the possibility of peptide aggregates 
could be excluded. Also, there was a difference between diffusion coefficients of neutral 
and anionic GUVs as in previous case with low concentration of TAT peptides. 
 
 
3.1.5.  Monte Carlo simulations 
 
The Monte Carlo simulations were performed according to the model presented in chapter 
2.9. In neutral membranes, theoretical calculations showed that TAT peptides are located 
at distances higher than 20 Å from the midplane so, according to model, on membrane 
surface or next to it (Figure 3.10 (A)). In anionic GUVs the peptides are partially inserted 
in the headgroup of lipids, being located at 15 Å from the midplane (Figure 3.10 (B)). 
Also the hydrophocity (p) is increased for anionic membranes compared to neutral ones, 
so the probability for peptides to be in the vicinity of hydrophobic core is higher. 
 
3. Results and discussion 
 66
Simulations suggested that the peptide does not translocate the bilayer neither in neutral 
nor in anionic model membranes.   
Thus, the theoretical simulations were in a good agreement with the experimental results. 
These showed a stronger interaction of TAT peptide with anionic membranes, reflected by 
a reduced value for diffusion coefficients comparing to neutral GUVs. Also there was 
detected any translocation of the peptide. 
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Figure 3.10: Distance distribution of TAT peptide from the membrane midplane. Hydrophobicity is 
denoted as p. (A) The membrane is neutral; (B) The membrane contains 15% anionic lipids. 
 
 
 
3.1.6. Discussion 
 
The diffusion coefficients of a lipid tracer molecule, TR-DHPE, within GUV membranes 
made from lipid mixtures known to form liquid-ordered, liquid-disordered membranes 
were measured. This part of the study provided us with reference mobility values for lipids 
within the employed model membranes. We found that the mobility of TR-DHPE varied 
from 0.5 to 2.5 µm2/s for liquid-ordered and liquid-disordered membranes respectively. 
Furthermore, the addition of 15 mol % anionic lipids did not change the tracer mobility 
considerably. Similar as in experiments using FCS, we detected two different diffusion 
 
3. Results and discussion 
 67
coefficients when systems of lipids were employed, which are known to exhibit 
micrometer-sized domains of different composition and mobility [101]. 
We observed a strong and fast labelling of the GUV surface, depending on peptide 
concentration, which was more efficient for anionic GUVs compared to neutral GUVs. 
The binding did not show any lipid domain correspondence. GUVs were labelled within 
minutes, but no TAT was detected within the GUV interior.  
The mobility of TAT peptides on the vesicle surface was significantly higher than that of 
the membrane-immersed tracer molecules and independent on the hydrophobic phase of 
the model bilayer. In contrast to the lipid mobility the diffusion of the cationic TAT 
peptides was clearly slowed down in membranes containing 15 mol % anionic lipids. 
Altogether, these observations suggested that the TAT peptides were not immersed within 
the viscous hydrophobic domain of the membrane, but were rather “floating” on the head-
group domain of the bilayer. In the presence of anionic lipids in the membrane, the 
cationic TAT peptides are attracted by the negatively charged lipid head-groups causing 
prolonged attachments and a reduced mobility of peptides in comparison to neutral 
membranes. The latter observation suggested a deeper insertion of the cationic peptide 
into the anionic lipid head group region. The “floating” of peptides on neutral membranes 
and the slightly immersion in the anionic bilayers were confirmed by Monte Carlo 
simulations. Theoretical calculations localized the peptides at 20 Å in neutral membranes 
and at 15 Å in anionic membranes from the midplane, so in the lipid headgroup.  
Quantitative studies of TAT-mediated cell translocation of cargo molecules suggested the 
existence of a limiting concentration, at which effective penetration would occur [29]. We 
also detected a strong concentration-dependent tendency of the TAT peptides to 
accumulate on the model bilayers. Therefore we studied the peptide mobility also at a 
concentration, at which extensive TAT-membrane association would lead in cells to 
peptide uptake (∼ 2 µM). However, we found no significant change in TAT mobility even 
in this situation. One should mention that no glycosaminoglycans were present in the 
GUV membranes, which were suggested to play an important role in mediating 
interactions between TAT and cell membranes ([14], [15]), but still a strong binding, 
probably due to charge interaction, was obvious.  
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3.2.  Interaction of TAT peptides with high content of 
anionic lipid PS 
 
In previous experiments, we observed that electrostatic interactions plays an important 
role in interaction of TAT with model membranes and probably also in the penetration 
process. Therefore, we studied the peptide binding to vesicles prepared from anionic and 
zwitterionic lipids as function of surface charge density. Anionic GUVs were prepared 
from mixtures of DOPC/DOPS/cholesterol or DPPC/DPPS/cholesterol with a gradually 
increased content of PS in order to follow the effect of the anionic charge on TAT 
mobility and possibly translocation. 
 
 
3.2.1.  Neutral membranes with 20 mol % cholesterol 
 
The literature contains numerous studies about influence of cholesterol on membrane 
dynamics or domain distributions. It still seems that between 20 and 33 mol % cholesterol 
there are no major changes in dynamics of model membranes [102]. Therefore, in the next 
experiments the amount of cholesterol was always 20 mol % for a more comprehensible 
expose of the results. The experiments of lipid mobility in GUVs with 20 mol % chol, this 
time were repeated to have a reference for membrane dynamics also at this content of 
cholesterol. GUVs with liquid-ordered phase formed by DPPC and cholesterol or liquid-
disordered formed by DOPC and cholesterol were prepared for these experiments. The 
exact lipid mixtures were summarized in Table 3.6 in 3.2.2.2. The mobility of the tracer 
molecules within the model bilayers was evaluated by a jump distance analysis according 
to eq. 2. As expected the distributions could well be described by eq. 2 with a single 
diffusive species only, and yielded a diffusion coefficient of D =2.20 ± 0.02 µm2/s for 
DOPC compared to GUVs comprising DPPC with D= 0.56 ± 0.02 µm2/s (Figure 3.11).  
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Figure 3.11: Interaction of TAT peptides with neutral model membranes containing PC Jump 
distance analysis for TR-DHPE in neutral GUVs: DPPC (A) or DOPC (B). TR-DHPE moves more rapidly 
within GUVs known to have an unordered phase with a diffusion coefficient D of 2.20±0.02 μm2/s 
compared to GUVs known to comprise an ordered phase (D=0.56±0.01 μm2/s). 
 
 
 
 
3.2.1.1. CLSM imaging of TAT peptide-membrane interaction using 
neutral GUVs 
 
As previous, to examine the TAT peptide interaction with the model membranes, we 
incubated the GUVs with R-TAT or AF-TAT contained in glucose solution. Interaction of 
TAT peptides with neutral GUVs was monitored as a function of time by confocal laser 
scanning microscopy (Figure 3.12). Over a time period of 30 min the fluorescence at the 
GUV surface increased upon incubation with 2 µM of R-TAT, but no fluorescence was 
detected inside of the GUVs. Even in a special case, where a GUV contained several 
internal membranes, connected to the outer membrane as could be seen in the DIC image, 
no labelling of the inner membranes was observed (see arrow in Figure 3.12, DIC image at 
30 min). The peptides were not able to translocate across the membrane at TAT peptide 
concentrations up to 2 µM under the given experimental conditions. Similar results were 
obtained also for AF-TAT. 
 
 
3. Results and discussion 
 70
 
Figure 3.12: Confocal imaging of TAT peptide-membrane interaction with neutral GUVs in 
glucose solution. The upper panel shows the time series of DIC images of the GUVs and the lower 
panel illustrates the confocal fluorescence images of the GUVs incubated with 2 μM R-TAT in the 
rhodamine fluorescence channel. R-TAT does not translocate, but just accumulates on the GUV 
membranes. The arrow indicates a GUV containing several internal membranes, which appeared 
connected to the outer membrane. The inner vesicles were not labelled by the peptide indicating that 
there was no internalization of TAT.  
 
 
 
3.2.1.2. Lateral mobility of single TAT on neutral GUVs surfaces 
 
The model neutral GUVs were incubated with 0.25 nM AF-TAT for 30 min in order to 
study the mobility of TAT peptides at membrane surface. A respective jump distance 
analysis clearly demonstrated a significantly higher mobility of AF-TAT compared to 
membrane-embedded tracer molecules (Table 3.5). The mobility of the AF-TAT peptide 
on the GUV surface was virtually identical for DOPC- and DPPC-based GUVs within the 
precision of the measurements. All jump distance histograms could well be fitted using a 
single diffusion component. The mobility on the neutral GUV surfaces was DTAT= 5.3±0.3 
µm2/s for GUVs prepared form DPPC/cholesterol and DTAT= 5.2±0.1 µm2/s for DOPC/ 
cholesterol containing GUVs. This confirmed the previous results from 3.1., that TAT 
peptide motion was independent of the internal lipid bilayer structure.  
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Table 3.5: AF-TAT mobility on GUVs 
Sample 
(Cholesterol 20 mol %) 
DPPC DOPC DOPC /DPPS = 80-x /x 
X = 20 X = 30 X =40  
D1,SPT  [µm2/s] 
 
5.3±0.3 
 
5.2±0.1 4.0±0.1 3.9±0.2 4.1±0.2 
 
 
 
 
3.2.2.  Interaction of TAT peptides with anionic model 
membranes 
 
Anionic GUVs were prepared from mixtures of DOPC/DOPS/cholesterol or 
DPPC/DPPS/cholesterol with a gradually increasing PS content from 20 to 40 mol %, in 
order to follow the effect of the anionic charge on TAT peptide mobility and possibly 
translocation.  
 
 
3.2.2.1. Imaging and tracking of single lipid analogs within anionic 
GUVs 
 
Following the analysis of lipid tracer mobility in neutral GUVs similar measurements 
were performed for anionic GUVs containing 40 mol % PS and 20 mol % cholesterol. The 
lipid tracer TR-DHPE was imaged within anionic liquid-ordered and liquid-disordered 
GUVs containing DPPC/DPPS and DOPC/DOPS, respectively. As previous, the mobility 
of the tracer molecules within the bilayers was quantified by a jump distance analysis. The 
histogram data could well be fitted by a single diffusion component (Figure 3.13). Similar 
to neutral membranes, TR-DHPE moved more rapidly within GUVs with a liquid-
disordered phase with a diffusion coefficient D of 2.01±0.01 μm2/s compared to GUVs 
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with liquid-ordered phase, D=0.54±0.01 μm2/s. The presence of the charged lipid in a high 
percent did neither change the phase behaviour nor the lipid tracer mobility considerably. 
 
 
 
Figure 3.13: Mobility of lipid tracers in anionic model membranes 
Jump distance analysis for TR-DHPE in anionic GUVs: (A) DPPC/DPPS and (B) DOPC/DOPS. The 
anionic charge was 40 mol %.  
 
 
 
3.2.2.2. CLSM imaging of TAT peptide-membrane interaction using 
anionic GUVs 
 
CLSM experiments were performed in DOPC/DOPS/cholesterol or 
DPPC/DPPS/cholesterol lipid mixtures containing 20, 30 and 40 mol % of PS (Table 3.6 
for membrane composition). An increase over 40 mol % of PS resulted in the failure of 
GUVs formation by electroswelling. Anionic GUVs were incubated with 2 µM AF-TAT 
containing glucose solution. A distinct labelling of the GUVs was already visible after 5 
min for 20% PS and 2 min for 30% and 40% PS. The labelling of the anionic GUVs was 
significantly stronger than that of neutral GUVs at the same microscope settings. At 40 
mol % PS TAT peptide fluorescence was observed within GUVs indicating peptide 
translocation across the bilayer (Figure 3.14). 
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Table 3.6: Composition of giant unilamellar vesicles (GUVs). 
 
Lipids, mol % 
Saturated Unsaturated 
 
GUVs 
(Cholesterol 
20 mol %) DPPC DPPS DOPC DOPS 
neutral 80 - 80 - 
60 20 60 20 
50 30 50 30 
 
anionic 
40 40 40 40 
 
 
 
Figure 3.14: Interaction of TAT peptides with anionic model membranes [122] Confocal imaging 
of TAT peptide labelled with Alexa Fluor 647 interacting with anionic GUVs: (A) membranes with 20 mol 
% PS, (B) membranes with 30 mol % PS, and (C) membranes containing 40 mol % PS. The upper plots 
quantify the intensity of fluorescent TAT peptides along a line across the GUVs shown in the images in the 
central image panel. The internalization of TAT peptide can clearly be seen in (C). All experiments were 
done in the presence of 40 kDa dextran labelled with fluorescein (lower panel). Time of observation was 30 
minutes. Scale bar, 20 µm.  
 
 
In order to control the overall membrane integrity, this experiment was performed in the 
presence of a 40 kDa fluorescein-labelled dextran, which was imaged in a separate 
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fluorescence channel (Figure 3.14, lower panel). This dextran has a Stokes radius of 4.3 
nm [123]; [124] and remained completely excluded from the GUVs at AF-TAT 
concentrations of 2 µM. After 20 to 30 min a few vesicles with 40% PS began to deform, 
break and release their inner content (see Figure 3.14 (C), the lower GUV and Figure 
3.15). 
 
 
Figure 3.15: Confocal images of GUVs with 40 mol % PS in presence of 2 μM AF-TAT 
(A) after 20 min of incubation with the TAT peptide. There was a special case where the TAT import could 
be well observed in a GUV containing two internal membranes; (B) after 30 min a several GUVs already 
disappeared. 
 
 
The CLSM images suggested an increasing interaction of the positively charged peptides 
with the increasing surface charges in anionic bilayers. Thus, we examined whether 
amount of anionic charge would have an impact on the TAT mobility on the GUV surface. 
For SPT experiments, the GUVs comprising 20, 30 and 40 mol % PS were incubated with 
0.25 nM AF-TAT for 30 minutes. In all cases the diffusion coefficient was D=4.0±0.2 
µm2/s without a detectable mobility difference in the absence or presence of translocation 
(Figure 3.16 (A-C)). A difference, however, was observed for TAT peptide mobility on 
neutral versus anionic GUVs (Table 3.5). The mobility of TAT on the neutral GUV 
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surfaces was faster than on the anionic GUVs. The average diffusion coefficient on the 
neutral GUVs was DSPT=5.3±0.2 µm2/s, whereas it amounted only to DSPT=4.0±0.2 µm2/s 
on anionic GUVs indicating an increased binding strength of the cationic peptides to the 
anionic GUVs. 
 
 
   Figure 3.16: The histograms show the analysis of AF-TAT diffusion on anionic GUVs with (A) 20 
% PS, (B) 30 %PS, and (C) 40 % PS. [122] 
 
To gain deeper insight into the membrane translocation of TAT peptide in GUVs with 40 
mol % PS and to test the hypothesis of a pore formation, we incorporated different water 
soluble fluorescent tracer molecules with increasing molecular weight (Alexa647-
maleimide 1.3 kDa, Alexa546- dextran 3 kDa, Alexa546-dextran 70 kDa) inside the 
GUVs [125]. If there is any lytic effect induced by the peptide, an efflux of the dyes 
should be observed by confocal microscope. After peptide addition the tracer fluorescence 
inside the GUVs was followed as a function of time (Figure 3.17 and 3.18). 
Indeed, these experiments revealed the complete release of Alexa647 within 20 minutes. 
For a few GUVs the break of the membrane was observed in a similar way to the 
experiments without internal tracers (Figure 3.17(A)). For the 3 kDa dextran, an efflux of 
50% from the tracer was observed. In contrast, the 70 kDa dextran molecules remained 
included in the GUVs. Figure 3.18 shows plots corresponding to internalization of TAT 
peptide (A) and efflux of tracers (B) in GUV with 40 mol % PS. The measured 
fluorescence intensity values representing the AF-TAT were normalized to the outside 
intensity. In Figure 3.18(B) is shown normalized fluorescence intensity for the leakage of 
tracers loaded inside of GUVs: AF647 maleimide, Alexa546-dextran 3 kDa and 
Alexa546-dextran 70 kDa.  
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Figure 3.17: Pore 
formation by TAT peptides in 
GUVs containing 40 mol% PS. 
 
 (A) The upper panel 
shows the binding and 
translocation of 2 µM R-TAT, 
and the lower panel the 
leakage of Alexa Fluor 647, 
and final GUV disruption.  
(B) Upper panel, 
binding and translocation of 
AF-TAT peptide, lower panel 
shows the partial release of 3 
kDa dextran labelled with 
Alexa Fluor 546.  
(C) Upper panel, AF-
TAT, lower panel 70 kDa 
dextran labelled with Alexa 
Fluor 546. This large dextran 
remained included within the 
GUVs. Scale bar, 20 µm. 
[122] 
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Figure 3.18: Internalization of TAT peptide (A) and efflux of tracers (B) in GUV with 40 mol % 
PS as presented in Figure 3.18. The solid line represents the exponential fit. 
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In absence of any TAT, the GUVs were stable even after 24 h, and no fluorescent content 
was released. To verify that the observed fluorescence decay was not due to 
photobleaching of the tracers we performed control experiments in similar conditions but 
without peptides. There was no change in fluorescence intensity for a similar number of 
images in these experiments (see Figure 3.19). So, we concluded that the previous release 
of the tracer molecules from the vesicles was due to TAT peptide induced pores in the 
GUV membranes. 
 
 
Figure 3.19: Control experiments for Alexa Fluor 647 and Alexa Fluor 546 photobleaching 
The images show GUVs loaded with fluorescent markers in the absence of the TAT peptide. The 
fluorophores were stable; there was no change in fluorescence intensity even after repetitive imaging scans. 
 
 
 
3.2.3.   Monte Carlo simulations 
 
The Monte Carlo simulations for interaction of TAT peptide with PS membranes were 
performed for different mol % of anionic lipids, up to 100, according to the model 
presented in 2.9. The simulations suggested that the probability of peptide to insert in the 
hydrophobic core of the lipid membrane increases with the content of anionic charge 
(Figures 3.20 and 3.21). In Figure 3.20 is shown that at 15 mol % PS the peptide is 
localised in the headgroup region (after 15 Å from the membrane midplane). Over 30 % 
anionic charge the peptide hydrophobicity (p) increased, meaning that the peptide is 
situated at the border or inside of hydrophobic core of bilayer.  
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Figure 3.20: The distance 
distribution of TAT in a membrane 
containing anionic lipids (0, 15, 30, 40, 
50, 60, 70, 80, 90, 100 mol % PS). 
 
 
 
 
Figure 3.21: Inner conformations versus ratio of anionic lipids. Inner conformations are considered 
at least adsorbed to the membrane.  
 
 
Figure 3.21 shows the plot of inner conformation against the content of PS. Inner 
conformation implies that the peptide is at least adsorbed on the membrane. At anionic 
content of 40%, the probability of the peptide to be inserted in the hydrophobic core is 
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almost 50%, so the possibility of translocation is highly increased compared to neutral or 
containing 15 mol % PS membranes. In conclusion, if the amount of anionic charge is 
high enough, this could be a sufficient condition to favour the translocation. Interestingly, 
even for pure anionic membranes the translocation was not 100 %, maximum being 60 %.   
For the theoretical model of the membrane see Figure 2.7. 
 
 
 
3.2.4.  Discussion 
 
The experiments from chapter 3.1 revealed stronger interactions of TAT peptide with 
membrane containing anionic lipids comparing to neutral ones. Therefore the content of 
PS from GUVs composition was gradually increased up to 40 mol %. 
Again, to have a reference for peptides mobility, the diffusion of the lipid tracer molecule 
TR-DHPE, within the membranes of GUVs made from lipid mixtures based on PC and PS 
was analysed by high-speed and high-sensitivity single molecule tracking. We found that 
the mobility of the tracer in membranes containing 40 mol % PS is 0.54±0.01 and 
2.01±0.01 µm2/s for liquid-ordered and liquid-disordered phases, respectively. The 
diffusion coefficients did not differ in anionic membranes containing up to 40 mol % PS 
comparing to neutral ones for the same hydrophobic chains confirming that the anionic 
charge of the headgroup does not significantly modify lipid mobility. 
To analyse the general features of TAT peptide interaction with the chosen model 
membrane systems the GUVs were incubated with red-fluorescent TAT peptides in 
glucose solution, in presence of 40 kDa green-fluorescent dextran molecules for checking 
overall integrity of the vesicles. TAT peptides were not able to traverse the membrane at 
concentrations up to 2 µM in GUVs with 20-30 mol % PS since no fluorescence was 
detected within the vesicles.  In this case, imaging of single TAT peptide molecules on the 
surface of the GUVs revealed that the peptide mobility was significantly higher than that 
of the lipids and not depending on the lipid phase confirming previous results from 
chapter 3.1 that TAT peptides are not inserted but rather floating on the membrane. But, 
when the molar ratio of the anionic lipid PS in the model membrane was increased to 40 
mole % TAT peptides were observed inside of GUVs. Also, in some cases, the vesicles 
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became so unstable that they broke and released their content. Simultaneously, the 
mobility of the peptides was measured by SPT. Even at the highest anionic charge 
concentration examined –with ongoing peptide translocation– a further reduction of TAT 
mobility compared with 20 or 30 mol % PS was not observed.  
 It has been suggested by computer simulations that TAT peptides may form pores within 
membranes [18], [20]. If TAT peptides can induce pores into GUV membranes, then small 
molecules should be able to flow across the membranes. To test this possibility, we 
performed efflux experiments with small fluorescent molecules. Indeed, GUVs 
comprising 40% PS in their membrane and containing the dye Alexa 647 released these 
1.3 kDa tracer molecules within 20 minutes after peptide addition. Approximately 50% of 
the fluorescent 3 kDa dextran tracer was released from GUVs within 30 minutes of 
incubation with 2 µM TAT. In contrast to these small molecules, 70 kDa dextran 
molecules remained within the GUVs. These observations suggested that the induced 
pores are small, up to 2 nm in diameter. Based on single molecule and confocal results we 
concluded that the TAT peptides first accumulate and associate to the membrane due to 
the electrostatic interactions. At a certain concentration pores were formed, which allowed 
peptides and tracers to pass. The life time of the pores must be extremely short, because 
they were not observable by single molecule tracking. These results for TAT peptides 
confirmed recent data obtained by Herce et al. for another CPP and TAT peptide too [20]. 
They demonstrated the flow of ions across and thus the presence of pores within a black 
lipid membrane system in the presence of nona-arginine and TAT peptide. Also, the 
theoretical simulations showed a good agreement with our experimental observations. The 
calculations suggested a deeper insertion of TAT in the hydrophobic core while the 
content of anionic lipids is increased, pointing to the possibility of peptide translocation. 
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3.3. Interaction of TAT peptides with model 
membranes containing lipids inducing a negative 
curvature (PE) 
 
PE contains a primary amine group and PC a choline group. This leads to a small 
headgroup and a negative intrinsic curvature for PE unlike to the zero intrinsic curvature 
of “cylinder-shaped” PC. Also PS has a "cylindrical shape" with zero intrinsic curvature. 
PE is often found concentrated in the inner leaflet of membranes and plays an important 
role in the membrane fusion mechanism and vesicle formation [126]. For this reason, PE 
is associated with a wide variety of biological functions including cell division, growth, 
reproduction, and motility [127]; [128]. In bacterial membranes is the most abundant 
phospholipid (see Table 1.3 for composition of E. coli). PE has a role in bacterial growth, 
function of enzymes as folding of lactose permease. In most cases it acts like protein 
chaperones that assist the non-covalent folding or unfolding and the assembly or 
disassembly of other macromolecular structures, without appearing in these structures 
when they perform the normal biological functions [129]. 
 
Table 3.7: Composition of GUVs membrane containing PE 
 
Lipids, mol % 
Saturated Unsaturated 
 
GUVs 
(Cholesterol 
20 mol %) DPPC DPPE DOPC DOPE 
70 10 70 10 
60 20 60 20 
 
 
50 30 50 30 
 
Since the previous experiments suggested that TAT interacts with lipid head groups rather 
than with the hydrophobic core, we investigated if the differences between PC and PE 
could induce changes in peptide mobility. It was not possible to generate vesicles by 
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electroformation from pure PE. Therefore, we prepared mixtures of PC/chol and PE. The 
prepared GUVs contained 10, 20 or 30 mol % PE and 20 mol % of cholesterol (Table 3.7). 
 
 
3.3.1.  Diffusion of single lipid analogs in model membranes 
containing PE 
 
The analysis of lipid tracer mobility in PE containing GUVs was done in a similar way to 
the experiments presented in the previous chapters. We examined two different lipid 
compositions, with liquid-ordered and liquid-disordered phases, containing 
DPPC/DPPE/cholesterol and DOPC/DOPE/cholesterol respectively, both with 30 % of 
PE. In spite of the fact that the hydrophobic core was identical to the GUVs containing PC 
and PS examined previously, now we observed significantly lower diffusion coefficients, 
i.e. 0.41±0.02 and 0.63±0.02 µm2/s (Figure 3.22). Obviously, the negative curvature of the 
phosphoethanolamine caused a distortion of the membrane topology which diminished 
lipid mobility significantly, especially for unsaturated lipids. 
 
 
 
Figure 3.22: Mobility of lipid tracers on model membranes containing PE 
Jump distance analysis for TR-DHPE in GUV membranes containing 30 mol % PE: (A) DPPC/DPPE/chol; 
(B) DOPC/DOPE/chol. The moblility of the tracer was significantly reduced in comparison to the PS and PC 
membranes discussed above. D found for (A) was 0.63±0.02 µm2/s and 0.41±0.02 µm2/s for (B) 
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3.3.2.  CLSM imaging of TAT peptide-GUVs interaction 
 
GUVs prepared from DOPC/DOPE/cholesterol and DPPC/DPPE/cholesterol were 
incubated with 2 µM AF-TAT in presence of fluorescein-labelled 40 kDa dextran to 
control the overall integrity of the bilayer. GUVs with molar fractions of PE from 10 
mol% to 30 mol % were examined. For 10% of PE we observed no visible peptide 
translocation, only accumulation on the membrane. Starting with 20 and 30% PE a clear 
TAT peptide translocation was observed after 30 min (Figure 3.23 A, B and C).  
 
 
 
Figure 3.23: Interaction of TAT peptides with model membranes containing PE [122] Confocal 
imaging of AF-TAT peptide interaction with GUV membranes comprising (A) 10 mol % PE, (B) 20 mol% 
PE and (C) 30 mol % PE. The upper plots show the intensity of TAT peptide fluorescence along the central 
line of the images below. Internalization of TAT peptides can clearly be seen in (B) and (C). All 
experiments were done in the presence of 40 kDa FITC-dextran in the outer medium (lower panel). 
Observation time was 30 minutes after peptide addition. Scale bar, 20 µm. 
 
 
In the upper panel from Figure 3.23 (B and C), it appeared that the peptide reached a 
higher concentration within the GUV than outside, which is obviously against 
thermodynamic principles. Control experiments revealed that this was due to the fact that 
different sugars were inside and outside of the GUVs. The presence of sucrose instead of 
glucose in the medium results in 80% increase in fluorescence intensity of the dye (Figure 
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3.24). The sugar-dependent fluorescence of dyes such as FITC or TRITC can even be used 
to quantify glucose concentrations [130]. 
 
 
Figure 3.24: A comparison of fluorescence intensity for Alexa-Fluor 647 in water and sugars. 
Addition of sugars dramatically increases the fluorescence intensity of the dye at the same concentration. 
Also, the concentration of sugars is identical, 250 mM.   
 
 
To check whether the translocation occurred due to pore formation, similar leakage 
experiments as in the case of GUVs containing PS were performed (Figure 3.25). The 
GUVs were filled up with Alexa Fluor 647 maleimide, 3 kDa and 70 kDa-dextran.  After 
incubation with 2 µM AF-TAT, Alexa Fluor 647 dye molecules were completely released 
from GUVs containing 30 mol % PE within 20 min. However, both fluorescent dextrans, 
3 kDa and 70 kDa, did not pass the respective GUV membranes. With these experiments 
we confirmed that the presence of TAT peptide induced pores in GUVs. In addition, we 
found that TAT peptides induce differently sized pores in PE comparing to PS containing 
membranes. The fluorescent 3 kDa dextran was released from PS but not from PE 
comprising GUVs. 
Figure 3.26 shows the plots corresponding to internalization of TAT peptide (A) and 
efflux of tracers incorporated inside of GUVs (B) in GUV with 30 mol % PE. The 
measured fluorescence intensity values representing the AF-TAT were normalized to the 
outside intensity. It should be mentioned here that it was difficult to quantify the amount 
of internalised peptide or released tracers due to difference in fluorescence intensity for 
glucose and sucrose.    
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Figure 3.25: Pore formation of TAT 
peptides in membranes containing 30 mol % 
PE [122]  
(A) The upper panel shows the 
internalization of R-TAT, and the lower panel 
shows the efflux of Alexa Fluor 647 from 
GUVs comprising 30 mol % PE.  
(B) Upper panel, internalization of 
AF-TAT; lower panel, no efflux of Alexa Fluor 
546 labelled 3 kDa dextran molecules was 
detected.  
(C) Upper panel, internalization of 
AF-TAT; lower panel, no efflux of Alexa Fluor 
546 labelled 70 kDa dextran molecules was 
detected. Scale bar, 20 µm. 
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Figure 3.26: Internalization of TAT peptide (A) and efflux of tracers (B) in GUVs with 30 mol % 
PE as presented in Figure 3.25. The solid line represents the exponential fit.  
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3.3.3.  Lateral mobility of single TAT on the GUVs surface 
 
To determine the mobility of peptides, SPT experiments were performed on GUVs 
containing 10, 20 or 30 mol % PE after an incubation with 0.25 nM AF-TAT in glucose 
for 30 minutes. Single AF-TAT trajectories were recorded, and the mobility characteristics 
were quantified by means of jump distance histograms (Figure 3.27 A, B and C).  For     
10 % PE, where no peptide translocation occurred, the mobility was similar to that on 
neutral GUVs, suggesting alike to this case, that the peptide was not incorporated into but 
floating on the membrane. Instead, for 20 % PE molar ratios, where a distinct TAT 
translocation was observed by confocal microscopy, the jump distance histogram was 
clearly bi-modal, and two diffusion coefficients were required for a satisfactory fit of the 
data. The higher coefficient, D1= 5.2±0.1 µm2/s, was similar to the values determined for 
TAT peptides moving on the GUVs surface. Interestingly, the second coefficient, D1= 
0.3±0.1 µm2/s, was even lower than the lipid mobility (Table 3.8). For GUVs with 30 % 
PE, the diffusion coefficients were even more reduced. The histogram for 10 mol % PE 
showed a very small fraction for a second component with a reduced mobility (Figure 3.27 
(A)). Therefore the jump distance histogram was fitted with two diffusion coefficients. To 
reduce fitting parameter correlation, for the second fit, the diffusion value was fixed to 0.3 
and the found fraction was only 4 %.  
 
 
   Figure 3.27: Interaction of TAT peptides with model membranes containing PE. 
The histograms show the analysis of AF-TAT diffusion on the respective GUVs with (A) 10 % PE, (B) 20 
%PE, and (C) 30 % PS. Scale bar, 10 µm. [122] 
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Table 3.8: AF-TAT peptide mobility on PE containing GUVs (DOPC /DPPE =80-x /x) 
Sample 
(Cholesterol 20 mol %) 
D1,SPT 
[µm2/s] 
Fraction 
1 
D2,SPT 
[µm2/s] 
Fraction 
2 
X = 10 5.2±0.1 0.96 *0.3 0.04 
X = 20 5.3±0.2 0.67 0.4±0.1 0.33 
X = 30 3.6±0.6 0.36 0.3±0.1 0.64 
* For this fit, the diffusion value was fixed to 0.3 to reduce fitting parameter correlation 
 
The presence of two distinct diffusion coefficients indicated that TAT peptides first attach 
to the membrane in relatively loose manner as in the other cases, probably due to the 
partially negative charge of PE. Then they could form some large molecular aggregates on 
or within the membranes, which comprise several lipid molecules. 
Therefore, a step forward to verify the possibility of aggregates formation would be to 
monitor the effect of TAT on the bilayer and to analyse the dynamic of lipids in the 
presence of 2 µM unlabelled peptide. So, we performed experiments with both saturated 
and unsaturated lipid chains in membranes containing 30 mol % PE labelled with the 
tracer TR-DHPE in glucose solution were 2 µM B-TAT were added. Surprisingly, the 
mobility of the lipids in PE membranes was not changed in presence of TAT, the diffusion 
coefficients being D=0.67 µm2/s for DOPC/DOPE/chol and D=0.44 µm2/s for 
DPPC/DPPE/chol (see Figure 3.28 for jump distance histograms).  
 
Figure 3.28: Interaction of B-TAT peptides with model membranes containing 30 mol % PE 
labelled with TR-DHPE. The histograms show the analysis of TR-DHPE diffusion in the respective GUVs 
comprising (A) DPPC/DPPE/chol and (B) DOPC/DOPE/chol.  
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A second component corresponding to aggregates mobility was not identified. So, the 
hydrophobic core of the membrane seems not to be affected by the TAT.  
Since the lower diffusion coefficient is not a consequence of lipids aggregates, then it 
should reflect the peptide mobility. Analysing the trajectories for TAT in GUVs with 
different mol % PE, these are comparable with those of the tracer lipids in 10 % PE 
membranes. Instead, for 20 and 30 mol %, the trajectories are shorter and more confined 
(Figure 3.29). We can conclude that the mobility of TAT peptide is slowed down in GUVs 
with higher content of PE and the second diffusion coefficient represents TAT mobility. 
 
 
 
Figure 3.29: Plots of two-dimensional diffusion trajectory of the tracer TR-DHPE in saturated 
membranes containing PE (A), unsaturated GUVs with PE (B) and the trajectories for AF-TAT peptide in 
membranes containing 10 mol % PE (C), 20 mol % PE (D) and 30 mol % PE (E) 
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3.3.4.  Discussion 
 
To have a reference for peptide diffusion, the mobility of the lipid tracer molecule TR-
DHPE, within the membranes of GUVs made from lipid mixtures based on PC and PE 
was analysed by single molecule tracking. We found that in membranes containing PE and 
PC the tracer molecules had lower diffusion coefficients compared to PC or PC/PS 
mixtures, although the used lipids contained the same hydrophobic chain. For liquid-
ordered membranes the mobility was 0.41 µm2/s and for disordered membranes it was 
reduced to 0.63 µm2/s. Obviously, PE introduced severe distortions of the membrane 
structure [131]. PE has a relatively small headgroup, which results in a significantly lower 
area per lipid leading to a high order of the hydrocarbon lipid tails and corresponding low 
lipid mobility. Furthermore, comparative studies of PE and PC using 2H-NMR showed 
that PE molecules tend to form inter- and intramolecular hydrogen bonds, including 
association with other lipid types [132]. The amine group as a hydrogen-donor can 
strongly interact with other phosphate/carbonyl groups or water, which functions as 
hydrogen-acceptors. Probably, these strong intermolecular interactions cause a further 
reduction of lipid mobility. 
To follow the general features of TAT peptides interaction with the model membranes we 
incubated pre-formed GUVs with AF-TAT peptides and 40 kDa FITC-dextran contained 
in glucose solution. Starting with 20 mol % of PE, the internalization of TAT was 
observed. Further increasing the PE mole fraction to 30 % yielded a higher translocation 
rate. However, any GUV destruction was not detected. Small tracer molecules were 
released from the GUVs, but neither 3 nor 70 kDa dextrans.  So the size of pores induced 
in PE membranes should be smaller than in PS containing GUVs, up to 1.3 nm in 
diameter. The pore formation was not observable by single molecule tracking, probably 
due to extremely short life time. These results for TAT peptides are in agreement with 
recent data obtained by Herce et al. [20]. They demonstrated the flow of ions across and 
thus the presence of pores within a black lipid membrane system in the presence of nona-
arginine and TAT peptide. 
Unlike anionic membranes with high content of PS, single molecule tracking of 
fluorescent TAT peptides on the surface of PE containing GUVs revealed two distinct 
 
3. Results and discussion 
 90
mobile fractions. One fraction had a distinct reduced mobility, D=0.3 µm2/s, and the other 
mobile fraction showed the mobility of TAT “floating” on the membrane with D=5.2 
µm2/s. The fraction of the slow mobility component increased by a factor of 3 when the 
PE content in the membrane was increased from 10 to 30%. Also at 10 mol % PE a very 
small fraction of the slow component was identified (only 4 %), suggesting that the 
peptide is inserted in the membrane but the concentration is not enough to form pores and 
translocate. Interestingly, this slow fraction was even less mobile than the lipids 
themselves in these membranes. This slow diffusion coefficient suggested the presence of 
large molecular complexes comprising TAT peptides and lipids. The experiments with 
labelled lipids and B-TAT 2 µM showed that peptide binding does not compromise the 
mobility of the lipid bilayer. Similar results were obtained with SAXS by [19] were, even 
at lipid: peptide ratio high as 1.15:1, the PE membrane was not affected by the peptide 
(Figure 3.28).  
 
Figure 3.30: The native inverted hexagonal 
diffraction pattern of DOPE (black) remains 
unchanged upon addition of TAT CPP (red). The two 
diffraction patterns can be superimposed [19]. 
 
 
This observation excluded the hypothesis that lipid aggregates like micelles were formed. 
Instead, the TAT peptide could bind to the PE headgroup by hydrogen bonds in a structure 
similar to a pore formation, inducing a decrease in peptide mobility. At certain peptide 
concentration, a pore could be generated and would be open for a while, to allow the 
efflux of tracer molecules. This hypothesis was sustained by examination of the TAT 
trajectories which were more confined in membranes containing at least 20 mol % PE.  
The Monte Carlo simulations were not performed for this situation because the model 
implies planar membranes and the effect of curvature induced by PE can not be simulated. 
 
3. Results and discussion 
 91
3.4.  Interaction of TAT peptides with model 
membranes at physiological salt concentration 
 
From bacteria to mammals, biological processes take place in salt solution. Maintaining a 
delicate balance of ions, biomembranes interact with different ion species. Considering the 
biological relevance of salt ions, the most important ones include Na+, K+, Cl-, Ca2+ and 
Mg2+. Monovalent ions such as Na+ and K+ are relevant in modulating the properties of 
plasma membrane. The divalent Ca2+ plays an important role in signal transduction 
pathways where it functions as second messenger signalling, e.g. in contraction of all 
muscle cell types, and it is a very good “cytosolic buffer” being stored inside of the cells 
in mitochondrial membranes or in the endoplasmatic reticulum [67]. 
All previous experiments (chapters 3.1-3.3) were done in sucrose/glucose solutions with 
all ions excluded from the medium. These conditions are though difficult to compare 
directly with those from live cell experiments. Hence, experiments in presence of salt 
solutions in order to approximate physiological conditions were also performed. For that, 
the GUVs generated from zwitterionic PC and anionic PS (20 mol %) with 20 mol % 
cholesterol were transferred into glucose solution containing 100 mM sodium chloride 
(NaCl).  
 
 
3.4.1.  Diffusion of single lipid analogs in model membranes in 
presence of 100 mM NaCl  
 
Similar to previous experiments, in order to obtain a reference for bilayer mobility, the 
lipids were mixed with the tracer TR-DHPE (10-7 mol %). The jump distance analysis 
showed that the diffusion coefficients for saturated and unsaturated chains remained 
almost unchanged in presence of 100 mM NaCl compared to the desalted conditions (see 
Table 3.9 and Figure 3.31). Thus in neutral membranes, TR-DHPE moved more rapidly 
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within GUVs known to comprise an unordered phase with a diffusion coefficient of 
D=2.07±0.07 µm2/s compared to GUVs with an ordered phase, D=0.51±0.01 µm2/s. 
Similar in anionic membranes, TR-DHPE diffused faster within GUVs with an unordered 
phase with a diffusion coefficient of D=2.0±0.07 µm2/s compared to GUVs, which had an 
ordered lipid phase, D=0.50±0.01 µm2/s. 
 
 Table 3.9: TR-DHPE mobility within GUVs in 100 mM  NaCl  
DSPT, [µm2/s] 
Saturated Unsaturated 
DPPC DPPC/DPPS DOPC DOPC/DOPS 
 
GUVs, 
20 mol % chol 
NaCl 100 mM 0.51±0.01 0.50±0.01 2.07±0.07 2.0±0.07 
 
 
 
 
Figure 3.31: Analysis of TR-DHPE diffusion in neutral and anionic GUVs in 100 mM NaCl 
 (A) jump distance analysis for TR-DHPE in neutral GUVs with liquid-ordered lipid phase; (B) jump 
distance analysis for TR-DHPE in anionic GUVs with liquid-ordered lipid phase; (C) jump distance analysis 
for TR-DHPE in neutral GUVs with liquid-disordered lipid phase; (D) jump distance analysis for TR-DHPE 
in anionic GUVs with liquid-disordered lipid phase.  
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3.4.2.  CLSM imaging of TAT peptide-GUVs interaction in 
NaCl solution 
 
To observe the general interaction between TAT peptide and model membranes under the 
new conditions, the GUVs were incubated with 2 µM AF-TAT and dextran molecules 
with molecular weight of 40 kDa labelled with FITC in glucose solution containing 100 
mM NaCl. Neutral or anionic GUVs, with saturated and unsaturated hydrophobic chains 
were examined.  In contrast to the “unsalted” conditions experiments, AF-TAT 
translocation into GUVs was observed already after a few minutes. Besides this, in a 
physiological NaCl solution TAT binding to GUVs was completely abrogated.  Figure 
3.32 shows an experiment for anionic GUVs prepared from DOPC/DPPC/DOPS/Chol = 
30/30/20/20 incubated with 2 µM of AF-TAT.  
 
 
Figure 3.32: TAT peptide interaction with GUVs.  Confocal images of the anionic GUVs incubated 
with 2 µM AF-TAT in a glucose solution (A) and glucose solution containing 100 mM NaCl and 4 µM 40 
kDa FITC-dextran (B). 
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Figure 3.32 (A) shows for comparison interaction between GUVs and TAT peptide in 
glucose solution without any salt in the external medium. In Figure 3.32 (B), in presence 
of 100 mM NaCl AF-TAT rapidly translocated across the GUV membrane (left panel). It 
took about 30 min until the AF-TAT concentration completely equilibrated inside and 
outside the GUVs. Similar results were obtained for neutral GUVs. To verify the 
intactness of GUVs, the experiment was performed in the presence of a 40 kDa 
fluorescein-labelled dextran, which was imaged in a separate fluorescence channel (right 
panel).  
 
 
3.4.2.1.  Influx of tracers in presence of TAT peptide 
 
Since we observed that behaviour of TAT peptide was completely different in salt solution 
for the same composition of GUVs and the same peptide concentration, additional 
experiments were performed in order to understand this difference. So, neutral and anionic 
vesicles were incubated simultaneously with 2 µM TAT peptide and tracers with different 
molecular weights: Lucifer Yellow, Alexa Fluor 488, 4 kDa and 40 kDa FITC-labelled 
dextrans. The purpose was to check whether the TAT peptide translocation was due to 
pore formation.  
Generally, the translocation speed of TAT peptide varied widely between different 
vesicles. In an experiment with several GUVs of different diameters, incubated with 2 µM 
TAT peptide and Lucifer Yellow one could observe that under the same conditions the 
translocation of peptides and tracers occurred with different velocities (Figure 3.33). 
Lucifer Yellow was a dye with a molecular weight of 386 Da and it was internalized 
simultaneously with AF-TAT. In absence of the peptide it remained excluded from GUVs. 
Peptide translocation was not GUVs size dependent. The vesicles (1 and 3) and (2 and 4) 
respectively had the same diameter, but only 1 and 4 were fully loaded with TAT peptide 
or tracer after 30 minutes.  
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Figure 3.33: Internalization of TAT peptide and Lucifer Yellow in GUVs in presence of NaCl 100 
mM. In the lower panel the measured fluorescence intensity values were normalized to the external intensity. 
The solid line represents the exponential fit. Scale bar 20 µm. 
 
 
Similar results were obtained for Alexa Fluor 488. AF-TAT peptides equilibrated across 
the GUVs membrane within 30 min. Also the small dye AF488 was internalized, as 
expected (Figure 3.35). Beside this, a certain internalization of the 4 kDa dextran was 
observed (Figures 3.34 and 3.35). Like in the experiments from previous chapters, no 
influx of FITC-dextran 40 kDa was registered. 
To be sure that the observed effect of dye internalization occurred only due to possibly 
pore formation induced by TAT peptide, control experiments without the peptide were 
done. As expected, there was no influx of the tracers in GUVs in absence of TAT (data not 
shown). 
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Figure 3.34: Internalization of TAT peptide and FITC-dextran 4 kDa in presence of 100 mM NaCl 
in a neutral GUV. The plots of normalized fluorescence intensity are depicted in Figure 3.35 A. Scale bar 20 
µm 
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Figure 3.35: Internalization of TAT peptide and tracers in GUV in presence of NaCl 100 mM.  
(A) Translocation in neutral GUVs (DOPC/DPPC/chol); (B) Translocation in anionic GUVs 
(DOPC/DPPS/chol).  The measured fluorescence intensity values corresponding to AF-TAT and dye 
accumulation inside of GUVs were normalized to the external intensity. The solid line represented an 
exponential fit. The data points were averaged for 5 vesicles. 
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3.4.2.2.  Efflux of tracers in presence of TAT peptide 
 
To acquire more about the translocation way, similar leakage experiments as in case of 
GUVs containing PS or PE were performed. Fluorescent tracers with different molecular 
weights (Alexa488-maleimide, 1.3 kDa, Alexa546-dextran 3 kDa and Alexa546-dextran 
70 kDa) were incorporated inside the GUVs. After incubation with 2 µM AF-TAT, Alexa 
Fluor 488 dye molecules were completely released within 20 minutes from both neutral 
and anionic GUVs (Figures 3.36, 3.37 and 3.38). The dextrans (3 kDa and 70 kDa) did not 
pass the GUVs membranes (Figures 3.37 and 3.38). For these tracers the data points were 
averaged for 5 vesicles. 
In the case of the small dyes, besides release of AF488, the GUVs were completely loaded 
with TAT within 20 min. For the bigger tracers which remained inside of the vesicles, the 
internalization of the peptide was less efficient for the same period of time (Figures 3.37 
and 3.38). 
  
 
 
Figure 3.36: Pore formation in DOPC/DPPC/chol (neutral) membranes in100 mM NaCl  
The upper panel shows the internalization of AF-TAT and the lower panel presents the efflux of Alexa Fluor 
488 from GUVs. The fluorescence intensity for both influx of TAT and efflux of the tracer is depicted in 
Figure 3.37. Scale bar 20 µm. 
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Figure 3.37: Internalization of TAT peptide in neutral GUVs (DOPC/DPPC/chol) and efflux of 
tracers in presence of 100 mM NaCl. (A) The measured fluorescence intensity values corresponding to the 
AF-TAT accumulation inside of GUVs were normalized to the external intensity. The solid line represents 
the result of an exponential fit. (B) Normalized fluorescence intensity for tracers with different sizes loaded 
inside of GUVs as indicated in the legend: AF488, 3 kDa Alexa546-dextran and 70 kDa Alexa546-dextran.  
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Figure 3.38: Internalization of TAT peptide in anionic GUVs (DOPC/DPPS/chol) and efflux of 
tracers in presence of NaCl 100 mM. (A) The measured fluorescence intensity values corresponding to the 
AF-TAT accumulation inside of GUVs were normalized to the external intensity. The solid line represents 
the exponential fit. (B) Normalized fluorescence intensity for tracers with different sizes loaded inside of 
GUVs. The data points were averaged for 5 vesicles. 
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To confirm that the observed fluorescence decay was not due to photobleaching, control 
experiments for AF488, without peptides were performed. There was no change in 
fluorescence intensity for a similar number of images in these experiments (data not 
shown). The control experiments for the tracers were presented in Chapter 3.2, Figure 
3.19. 
These experiments revealed again that generally, the translocation speed varied widely 
between different vesicles. Figure 3.39(A) exhibits a GUV with several internal vesicles, 
loaded with AF488. In the presence of 2 µM AF-TAT, the internalization of the peptide 
was observed (right) but the tracer efflux occurred at different rates. While the tracer was 
released from 2 vesicles, one is still fully loaded after 20 min. Figure 3.39 (B) shows the 
translocation of R-TAT (right) and the release of AF647 (left) after 20 min. Here are 
presented three GUVs with different diameters and one of them contains an internal 
membrane.  
 
 
 
Figure 3.39: Internalization of TAT peptide and efflux of tracers in 100 mM NaCl after 20 min. (A) A 
GUV with several inner vesicles loaded with AF488 (left) and AF-TAT peptide (right) 2 µM; (B) GUVs 
containing AF647 tracer (left) and translocation of R-TAT (right). Details are given in the text. Scale bar 20 
µm. 
 
 
 
3.4.2.3. Influence of cholesterol on TAT peptide translocation 
 
In a further experiment, cholesterol was excluded to check whether it plays a decisive role 
in TAT peptide behaviour. Figure 3.40 shows the efflux of AF488 in presence of 2 µM 
AF-TAT and 100 mM NaCl. The result was similar to the experiments with cholesterol. 
Also, the simultaneous internalization of TAT with small dyes was checked (Figure 3.41) 
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Figure 3.40: Pore formation in DOPC/DPPC = 80/20 (neutral) GUV in NaCl 100 mM 
(A) Upper panel shows the internalization of AF-TAT and the lower panel presents the efflux of Alexa Fluor 
488 from GUVs. Scale bar 20 µm. The fluorescence intensity for both influx of TAT and efflux of the tracer 
is depicted in (B). 
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     Figure 3.41: Internalization of TAT 
peptide and AF488 in DOPC/DPPC =50/50 
(neutral) GUV in presence of 100 mM 
NaCl. The data points were averaged for 5 
vesicles. 
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3.4.2.4. Influence of other ion types on TAT peptide translocation 
 
To verify whether specific ions played a decisive role in translocation process of TAT 
peptide in physiological salt condition, some other salts at the same concentration (100 
mM) were tested (Figure 3.42).  
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     Figure 3.42: Internalization of TAT peptide 
in DOPC/DPPS/chol=60/20/20 (anionic) 
GUVs in presence of 100 mM salt solution. 
The data points were averaged for 5 vesicles. 
 
CaCl2 is a salt which contains bivalent cations and CaCO3 has bivalent both, cations and 
anions comparing to NaCl with monovalent ions. Phosphate buffered saline (PBS) is a 
buffer solution commonly used in biological research. It is a salt solution containing 
sodium chloride, sodium phosphate, potassium chloride and potassium phosphate. The 
osmolarity and ion concentrations of the solution match those of the human body. The 
observed effect on TAT translocation was similar to NaCl for all these salt solutions 
(Figure 3.42). This observation leaded to the conclusion that the ion type and valence did 
not influence the internalization process. 
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3.4.3. Lateral mobility of TAT peptide on GUVs in NaCl 
solution 
 
We also attempted to measure the dynamics of the TAT peptide on GUV surfaces in the 
glucose medium containing 100 mM NaCl. Notably, it was not possible to detect or 
visualize any TAT signals neither on anionic nor in neutral GUVs under these conditions, 
using frame rates up to 450 frame/s. Also confocal imaging did not show any 
accumulation of peptides on GUVs membrane either.  
The diffusion constant of TAT peptides in pure buffer can be estimated based on the 
Stokes-Einstein equation [133]:  
r
TkD Bπη6=          (7)      
where D is the diffusion coefficient, 
KB is Boltzmann’s constant, 
T is the absolute temperature, 
η is viscosity 
r is the radius of the spherical particle 
 
For TAT peptide the radius is r=0.7 nm (calculate with software from http:// 
www.calctool.org/CALC/prof/bio/protein_length), glucose solution viscosity is 1.25 cP 
[134], kB is 1.38∗10-23 J/K, T is 298 K. The estimated value for diffusion coefficient was 
DTAT, sol=249 µm2/s which was too fast to be observed at the employed imaging frame 
rates [109]. 
It was not possible to observe the peptide on the surface of GUVs, but still SPT could 
offer information about changes of membrane mobility during the translocation process. 
For that, the membranes were marked with TR-DHPE 10-7 mol %. The GUVs created in 
this way were added in a solution containing 2 µM B-TAT (unlabelled) and 100 mM 
NaCl. Simultaneously, comparable experiments without ions were performed. The aim 
was to check whether the dynamic of membrane was changed in presence of TAT 
(without ions) and TAT/NaCl solutions. 
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3.4.3.1. Diffusion of single lipid analogs in GUVs in presence of 2 µM  
B-TAT 
 
The experiments with labelled GUVs and 2 µM B-TAT revealed that saturated 
membranes (neutral and anionic) were not affected by the high concentration of TAT 
peptide (see Table 3.10 and Figure 3.43). For a better comparison, the values for diffusion 
coefficients of the lipids without peptide (see chapter 3.2.1) were included in Table 3.10. 
 
 
 Figure 3.43: Analysis of TR-DHPE diffusion on neutral and anionic GUVs in presence of 2 µM B-
TAT. (A) jump distance analysis for TR-DHPE in neutral GUVs with liquid-ordered phase; (B) jump 
distance analysis for TR-DHPE in anionic GUVs with liquid-ordered phase; (C) jump distance analysis for 
TR-DHPE in neutral GUVs with liquid-disordered phase; (D) jump distance analysis for TR-DHPE in 
anionic GUVs with liquid-disordered phase. 
 
Surprisingly, in unsaturated GUVs several changes were observed in presence of 2 µM B-
TAT. In neutral DOPC/chol vesicles, the diffusion coefficient was slowed down to 
D=1.21±0.07 µm2/s compared to D=2.2±0.02 µm2/s in the absence of the peptide (see 
section 3.2.1). Possibly, the positively charged peptides interact with the headgroup of 
several lipids and induce formation of lipid clusters structures. As a consequence the 
diffusion coefficient of unsaturated lipids is reduced.  Probably, this effect was not 
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observed in saturated bilayers because these lipids were more ordered and less susceptible 
to form such clusters. The anionic DOPC/DOPS/chol GUVs showed two diffusion 
coefficients: D1=1.31±0.06 µm2/s and D2=4.44±0.60 µm2/s. The first one was alike 
mobility of neutral lipids and the second was similar to TAT peptide mobility (shown in 
chapter 3.2.1, Table 3.5). The presence of D2 could be explained by a possible association 
of TAT peptide with the lipid tracer TR-DHPE and it reflects TAT diffusion coefficient on 
model membranes. This aspect was not observed in neutral unsaturated membranes 
probably because positively TAT is electrostatically more attracted to negatively charged 
PS lipids. 
 
Table 3.10: TR-DHPE mobility within GUVs in a solution containing 2 µM B-TAT and 100 mM 
NaCl 
DSPT, [µm2/s]  
Sample DPPC DPPC/DPPS DOPC DOPC/DOPS 
B-TAT 0.54±0.01 0.56±0.01 1.21±0.07 1.31±0.06 
(71%) 
4.44±0.62 
(29%) 
B-TAT/NaCl 0.51±0.01 0.53±0.01 2.23±0.12 2.32±0.09 
Lipids 
mobility 
0.56±0.01 0.54±0.01 2.20±0.02 2.01±0.01 
 
 
3.4.3.2. Tracking of single lipid analogs in GUVs in presence of 2 µM 
 B-TAT and 100 mM NaCl 
 
Comparable experiments in salt solution, showed no change in the lipids mobility of the 
saturated and unsaturated GUVs (Table 3.10 and Figure 3.44). In 100 mM NaCl, the 
mobility of lipid tracers in DOPC/chol or DOPC/DOPS/chol membranes was not affected 
by the TAT peptide. This could be explained by a charge compensation of TAT with 
anions from the medium. On the other hand this was not surprising since CLSM 
experiments showed the absence of peptide membrane staining in salt solution, the 
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determinant factor for changing mobility of unsaturated lipids (see Figures 3.4, 3.12 and 
3.32).   
In presence of 2 µM B-TAT and 100 mM NaCl, TR-DHPE moved more rapidly within 
neutral GUVs known to comprise an unordered phase with a diffusion coefficient of 
D=2.23±0.12 µm2/s compared to GUVs with an ordered phase, D=0.51±0.01µm2/s. 
Similar, TR-DHPE diffuse faster within anionic GUVs with an unordered phase with a 
diffusion coefficient of D=2.32±0.09 µm2/s compared to GUVs, which exhibit an ordered 
phase, D=0.53±0.01 µm2/s. All these data corresponded to diffusion coefficients of lipid 
tracers in model membranes in absence of TAT and salt ions. 
 
 
  
Figure 3.44: Analysis of TR-DHPE diffusion on neutral and anionic GUVs in presence of 2 µM B-TAT and 
100 mM NaCl. ((A) jump distance analysis for TR-DHPE in neutral GUVs with liquid-ordered phase; (B) 
jump distance analysis for TR-DHPE in anionic GUVs with liquid-ordered phase; (C) jump distance 
analysis for TR-DHPE in neutral GUVs with liquid-disordered phase; (D) jump distance analysis for TR-
DHPE in anionic GUVs with liquid-disordered phase. 
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3.4.4.  Monte Carlo simulations 
 
Monte Carlo simulations were performed for both neutral and anionic membranes for 
different NaCl concentrations: 0.001 M, 0.005 M, 0.02 M, 0.1 M and 0.154 M (Figure 
3.45). The theoretical simulation showed no peptide internalization for any solution of 
different concentrations. 
 
Figure 3.45: Distance distribution of TAT peptide from the membrane midplane for different 
concentration of NaCl solution. 
 
 
 Figure 3.46: Peptide binding energy to the membrane as function of salt concentration. 
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Apparently Na+ ions shielded the membrane surface charge and TAT peptide was simply 
floating on the membrane. The simulations revealed that the binding strength of the 
peptide decreased with increasing of salt concentration (Figure 3.46). Thus the probability 
for translocation was reduced with increasing salt concentration. 
Altogether, the Monte Carlo simulations did not support or offer an explanation for TAT 
peptide translocation in salt solutions. On the other hand, this theoretical model had 
limitations [135] as explained in section 2.9. Both the peptide and membrane were 
described using a reduced representation. For the peptide, each residue was represented by 
two interactions sites. The simplicity made the simulations computationally possible. This 
involved inaccuracies in the calculations, especially those related to the solvation free 
energy (eq. 4), which strongly depended on the location of each atom. Moreover, for 
different ions species, only the charge and not the spatial volume of the ion was taken in 
account, so it did not allow studies of specific peptide-lipid interactions in atomic detail. 
Hydrogen bonds and salt bridges between the peptide and lipid, as well as the exact 
stereochemistry of the interaction were not taken into consideration. These limitations 
could be the reason for the discrepancy between experiment and computations.  
 
 
3.4.5.  Discussion 
 
Similar to the previous experiments, to have a reference, the mobility of the tracer TR-
DHPE within GUVs membrane made from saturated and unsaturated, anionic and neutral 
lipids, was evaluated. The result showed that the diffusion coefficients of lipid tracers in 
all situations remained unchanged in presence of 100 mM NaCl compared to the desalted 
condition. So, the membrane viscosity was not affected by ions at this concentration. This 
observation was actually expected. Petrache et al. [136] demonstrated with X-ray 
diffraction experiments that monovalent salts do not affect the membrane structure below 
1 M concentration. This result was confirmed later by EPR spectroscopy and DSC [137]. 
At concentration higher than 1 M both monovalent and divalent cations led to a significant 
increase in chain order, membrane thickness and membrane rigidity. These effects were 
more pronounced for CaCl2 than for monovalent salts. 
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CLSM experiments showed that physiological salt solutions dramatically changed the 
TAT peptide interaction with GUVs membranes. Any visible TAT binding to GUVs of all 
employed compositions was completely lost. The peptides now translocated efficiently 
into the GUV interior. However, in a previous study, a passive translocation of TAT into 
GUVs incubated with peptide in buffer solution was also observed [56]. In confocal 
images no membrane staining was detected, and also the extremely sensitive single 
molecule microscope did not reveal any trace of peptides on the GUVs surface.  
The experiments with GUVs loaded with differently sized dyes pointed to the pore 
formation mechanism in the presence of 2 µM TAT and 100 mM NaCl. The result was 
similar for neutral and anionic, liquid-ordered and liquid-disordered membranes. Also, the 
same experimental evidence was registered for GUVs without cholesterol and for other 
salt solutions at the same concentration, 100 mM (CaCl2, CaCO3 or PBS). 
In the SPT experiments for a membrane tracer in presence of 2 µM unlabelled TAT in 
glucose solution, no change in diffusion coefficients for liquid ordered membranes was 
detected. On the other hand, for neutral liquid-disordered GUVs a decrease in the mobility 
(D =1.21±0.06 µm2/s) suggested possibility of clusters formation induced by TAT 
accumulated on the membrane. In the anionic DOPC/DOPS/chol GUVs two diffusion 
coefficients were found. D1 =1.31±0.27 µm2/s was similar to the mobility of the 
membrane and D2 = 4.44 ± 0.11 µm2/s was close to peptide mobility. This value indicated 
a possible association of accumulated TAT on anionic membranes with the tracer TR-
DHPE.  
When GUVs labelled with TR-DHPE were added in glucose/NaCl solution containing 2 
µM B-TAT, the values for diffusion coefficients remained unchanged for both saturated 
and unsaturated lipid chains. 
TAT peptide contained 6 arginines and 2 lysines, which made it highly cationic. It was 
clear that molecules of such high charge density cannot traverse the biological or artificial 
membranes at physiological pH without the presence of counterions. It should be noted 
that arginines (and also lysines) were strongly hydrophilic and their high pKa values 
ensured that they did remain protonated at relevant physiological conditions (see Figure 
3.47).  
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Interpreted sequence 
RRRQRRKKRG 
 
  Hydrophilicity 
 
Net charge at pH 7.0:  8 
Iso-electric point, pI:13.1 
    Average hydrophilicity: 2.4  
    Ratio hydrophilic residues / total number of residues: 90% 
 
Figure 3.47: Hydrophilicity of TAT peptide estimated with the calculator based on Hoop-Woods 
scale from http://www.innovagen.se/custom-peptide-synthesis/peptide-property-calculator.asp 
 
 
It has been suggested that membrane transport of arginine-rich peptides like TAT may be 
accomplished by charge neutralisation at the membrane surface, possibly by the 
interaction with sufficiently hydrophobic counter-ions such as anionic phospholipids 
[138], [139]. The resulting ion-pairs might be membrane soluble due to the hydrophobic 
character of the phospholipid tails and hence able to travel across the membrane and enter 
the GUVs.  
The guanidinium groups from arginine had the property to form bidentate hydrogen 
bonds. It was shown that a guanidinium group had a very week association with a 
counterion such as a phosphate group in an aqueous environment (~ 0.2 kcal/mol) [140]. 
When the guanidinium group approached the surface of a lipid bilayer and local polarity 
decreased, its association with a phosphate counter ion increased dramatically (~2.6-6.0 
kcal/mol)[141]. While the complex moved into less polar membrane, this association was 
further strengthened. Figure 3.48 shows a schematic association of the guanidinium 
groups with the membrane constituents [142].  
The mechanism of ion pairing with the hydrophobic lipids was proved by water-octanol 
partitioning of arginine oligomers upon addition of sodium laurate, a surrogate for a 
membrane constituent [138]. The same authors proposed that the driving force for the 
passage of such ion pair complexes across the membrane was the membrane potential.  
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Figure 3.48: Representative associations of TAT based guanidinium transporter with anionic cell 
membrane constituents [142] 
 
 
 
In this study, in glucose solution no internalization was observed, just accumulation of 
TAT on the membrane. Instead, in the presence of salt solution, the peptides freely 
diffused into GUVs. Based on these observations and theoretical understanding, the 
suggested mechanism of traslocation is as follows: 
In glucose solution, the positively charged TAT peptides were attracted by the negative 
charges in GUVs membrane and they started to form associations through guanidinium 
groups with phosphate groups. According to Gouy-Chapman model of the double layer, 
the membrane surface has an electric potential called Zeta potential. In anionic GUVs the 
membrane surface was negatively charged but even zwitterionic lipids PC had a Zeta 
potential of -2.3±2.0 mV [143]. In presence of TAT, some negative charges were 
compensated by forming the mentioned ion-pairs and thus the potential in external leaflet 
of GUVs decrease comparing to the internal one. So, a membrane potential could be 
induced. In absence of salt ions, this potential was either on equilibrium or not enough to 
favour peptides translocation (see Figure 3.49). When 100 mM NaCl was added, the small 
Na+ ions were more accessible to the membrane and to compensate the negative charges. 
Obviously, this salt concentration was not enough to neutralize all the charges and some of 
them were compensated by ion-pairing with the guanidinium groups of TAT peptide. In 
this case, the difference between Zeta potential of bilayer surfaces was even higher than in 
glucose solution. So, one could expect to a greater membrane potential which favoured 
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TAT peptide translocation (Figure 3.49). Moreover, this proposed mechanism could 
explain the differences apperead in traslocation speed of TAT peptides (see sections 
3.4.2.1 and 3.4.2.2.). GUVs with a different membrane potential induced peptides 
internalization with different speeds, depending on potential value. 
 
 
 
 
Figure 3.49: Schematic associations of TAT peptide with membrane surface in a. glucose solution 
and b. glucose solution containing 100 mM NaCl 
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4. NKCS- A study extended to antimicrobial 
peptides 
 
Studies on interaction of TAT peptide with model membranes pointed to a pore formation 
mechanism similar to antibiotic peptides [19],[20], supported as well by the results from 
the chapter 3. Therefore, an extension of the studies to antimicrobial peptides, which 
supposedly act by membrane pore formation, should be most elucidative. NKCS, a 
derivative of NK-2 peptide is a promising member of peptide antibiotics [60]. It has 
efficient activity against both Gram negative and Gram positive bacteria. Two short 
derivatives, NKCS-[15-27] and NKCS-[15-27S] are included to study the partial activity 
of NKCS.  Bacterial plasma membranes mainly consist of phosphoethanolamine (PE) and 
a high amount of anionic lipids like phosphatidylglycerol (PG) (see Table 1.3 for E. coli). 
Hence, for the next experiments we prepared GUVs consisting of PC, PE and PG. This 
research was done in cooperation with Agnieszka Rzeszutek and Regine Willumeit from 
GKSS Research Center, Geesthacht, Germany. 
 
 
 
4.1. Results and discussion 
 
4.1.1.  Diffusion of single lipids analogs in model membranes  
 
In order to obtain a reference for the measurements on model membranes we started out 
by studying the dynamics of the model bilayer systems. For that, the mobility of 
fluorescent lipid tracer TR-DHPE in GUVs of different lipid compositions was measured 
by single particle tracking. Three different sets of experiments were performed: GUVs 
created from DOPC representing the mammalian membrane, DOPC/POPE = 60/40 mol % 
and DOPC/POPG = 70/30 mol % respectively, to mimic the bacterial membrane.   
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The GUVs were generated by electroformation; therefore it was not possible to obtain 
vesicles from pure PE or pure PG. The results revealed that DOPC and DOPC/POPG 
mixture exhibits a very similar dynamic behaviour and lipids in DOPC/POPE membrane 
had a lower mobility compared with the other two (Table 4.1 and Figure 4.2 A for 
DOPC/POPG and DOPC/POPE).  
 
Table 4.1: TR-DHPE mobility within GUVs 
Sample DOPC DOPC/POPG DOPC/POPE 
DSPT [µm2/s] 5.3 ± 0.4 5.0 ± 0.2 3.7 ± 0.2 
 
 
 
4.1.2.  CLSM imaging of NKCS peptide-GUVs interaction 
 
The GUVs prepared from DOPC, DOPC/POPG and DOPC/POPE were incubated with 
glucose containing 2 µM of NKCS, NKCS-[15-27] or NKCS-[15-27S] in order to verify 
the interaction of the peptides with the model membranes. To check the integrity of the 
GUVs, the experiments were performed in presence of FITC labelled dextran, 40 kDa, as 
in case of TAT peptide. The experiments showed no peptide internalization or 
accumulation on the pure DOPC membrane for NKCS and its shorter variants. Instead, for 
GUVs prepared from PE and PG lipids mixtures, both internalization and accumulation on 
the membrane were observed.  
To test the hypotheses of pore formation, different fluorescent tracer molecules with 
increasing molecular weight (Alexa Fluor 488-maleimide, 0.64 kDa, Alexa Fluor 546-
dextran 3 kDa; Alexa Fluor 546-dextran 70 kDa) were incorporated inside of the GUVs. 
After peptide addition the tracer fluorescence inside the GUVs was followed as a function 
of time. The observations after 30 minutes are summarized in the Table 4.2. 
The experiments revealed, as expected, no efflux of the tracers from GUVs consist of 
DOPC for all 3 peptides. Also, no fluorescence was detected inside of these vesicles. In 
GUVs prepared from DOPC/POPG mixture, the internalization of all 3 peptides but no 
dye release was registered for NKCS-[15-27] and NKCS-[15-27S]. Only NKCS seems to 
induce small pores, since the dye release was observed only for AF488 in PG based 
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GUVs. Instead, the experiments revealed the complete release of Alexa488 and Alexa546-
dextran 3 kDa within 30 minutes from DOPC/POPE membranes in presence of NKCS. 
For NKCS-[15-27] and NKCS-[15-27S], the tracers remained inside of GUVs in spite of 
the fact that peptides were internalized. Figure 4.1 shows the interaction of NKCS with 
GUVs prepared from DOPC, DOPC/POPG and DOPC/POPE loaded with 3 kDa dextran. 
 
Table 4.2: Effects of NKCS peptides on GUVs loaded with different tracers 
 NKCS NKCS-[15-27] NKCS-[15-27S] 
DOPC  
Peptide influx _ _ _ 
AF488 efflux _ _ _ 
Peptide influx _ _ _ 
Dextran 3 kDa efflux _ _ _ 
Peptide influx _ _ _ 
Dextran 70 kDa efflux _ _ _ 
DOPC/POPG  
Peptide influx + + + 
AF488 efflux + _ _ 
Peptide influx + + + 
Dextran 3 kDa efflux _ _ _ 
Peptide influx + + + 
Dextran 70 kDa efflux _ _ _ 
DOPC/POPE  
Peptide influx + + + 
AF488 efflux + _ _ 
Peptide influx + + + 
Dextran 3 kDa efflux + _ _ 
Peptide influx + + + 
Dextran 70 kDa efflux _ _ _ 
 
 
In order to examine the influence of ions present in the medium, a set of experiments with 
GUVs that were transferred not into glucose solution, but into 100 mM NaCl containing 
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glucose were performed. As before, the interaction of NKCS and its shorter variants with 
DOPC, DOPC/POPG and DOPC/POPE GUVs was tested. The experiments showed the 
same results as in the absence of salt solution (Table 4.2).  
 
 
Figure 4.1: Translocation and pore formation by NKCS peptide in GUVs 
(A) Incubation of GUVs prepared from DOPC. The upper panel shows no internalization or accumulation of 
NKCS in these GUVs. The lower panel shows no leakage of dextrans 3 kDa labelled with Alexa Fluor 546. 
(B) The upper panel shows the binding and translocation of 2 µM Dy-NKCS in GUVs formed by 
DOPC/POPG. The lower panel shows no leakage of dextrans 3 kDa labelled with Alexa Fluor (C) Upper 
panel, binding and translocation of NKCS peptide, lower panel shows the release of 3 kDa dextran labelled 
with Alexa Fluor 546 from GUVs formed by DOPC/POPE. Scale bar, 20 µm. 
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4.1.3.  Lateral mobility of single NKCS on the GUVs 
surface 
 
As in case of TAT peptide, SPT experiments of single fluorescently labelled NKCS 
peptides were performed on GUVs. For that the vesicles were incubated in glucose for 30 
minutes with 0.5 nM Dy-NKCS. Parallel, experiments for shorter sequences of NKCS 
were done. Single Dy-peptides trajectories were recorded and the mobility characteristics 
were quantified by means of the jump distance histograms (see Figure 4.2 C and F for 
NKCS). Table 4.3 shows the diffusion coefficients for NKCS, NKCS-[15-27] and NKCS-
[15-27S] peptides in GUVs prepared from DOPC, DOPC/POPG and DOPC/POPE 
respectively. 
The peptides showed the same mobility on DOPC membranes as lipids. Also, in order to 
register enough events generating the jump distance histograms, the concentration of the 
peptide was increased to 1 nM. This observation confirmed at the single molecule level as 
well, there is no interaction of NKCS with PC membranes. 
 Table 4.3: NKCS peptides mobility on GUVs 
Sample NKCS NKCS 15-27 NKCS 15-27S 
DOPC    
DSPT [µm2/s] 5.6±0.1 5.2±0.2 5.0±0.2 
DOPC/POPG    
D1,SPT [µm2/s] 4.9±0.3 4.4±0.3 4.7±0.3 
Fraction 1 0.59 0.69 0.71 
D2,SPT [µm2/s] 1.1±0.1 0.8±0.1 1.1±0.1 
Fraction 2 0.41 0.31 0.29 
DOPC/POPE    
D1,SPT [µm2/s] 5.2±0.7 5.2±0.7 5.9±0.5 
Fraction 1 0.7 0.69 0.80 
D2,SPT [µm2/s] 1.3±0.3 0.9±0.4 0.9±0.3 
Fraction 2 0.3 0.21 0.20 
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For GUVs prepared from DOPC/POPG and DOPC/POPE the jump distance histograms 
were clearly bi-modal, and two diffusion coefficients were required for a satisfactory fit of 
the data. One diffusion coefficient was similar to mobility of lipids and the other was 
much more reduced. 
To monitor the effect of antimicrobial peptides on the bilayer, the mobility of lipids in the 
presence of 2 µM unlabelled peptide was analysed. For that, GUVs labelled with the tracer 
TR-DHPE were added in glucose solution containing 2 µM unlabelled peptides. The 
diffusion coefficients for lipids were presented in Table 4.4. The histograms for TR-DHPE 
in DOPC/POPG and DOPC/POPE in presence of NKCS were illustrated in Figure 4.2 B 
and E respectively. 
 
Table 4.4: TR-DHPE mobility on GUVs incubated with 2 µM unlabelled peptides 
Sample NKCS NKCS 15-27 NKCS 15-27S 
DOPC    
D,SPT [µm2/s] 5.4±0.2 5.4±0.2 5.1±0.3 
DOPC/POPG    
DSPT [µm2/s] 3.6±0.3 3.8±0.3 3.9±0.2 
DOPC/POPE    
D1,SPT [µm2/s] 5.0±0.6 5.8±0.7 5.7±0.6 
Fraction 1 0.57 0.60 0.53 
D2,SPT [µm2/s] 1.2±0.1 1.3±0.3 1.4±0.2 
Fraction 2 0.43 0.40 0.47 
 
 
In these experiments DOPC mobility was not affected by the presence of 2 µM peptides. 
DOPC/POPG dynamic was reduced and only one component was required to fit the 
histograms in contrast to DOPC/POPE which showed the same diffusion coefficients as 
for peptides (Table 4.4). 
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Figure 4.2: (A) and (D) Jump distance analysis for TR-DHPE in GUVs prepared from 
DOPC/POPG and DOPC/POPE. (B) and (E) Jump distance analysis for TR-DHPE in PG and PE GUVs in 
presence of 2 µM unlabelled NKCS. (C) and (F) Jump distance analysis for 0.5 nM NKCS on GUVs formed 
by DOPC/POPG and DOPC/POPE respectively.  
 
4.1.4.  Discussions 
 
The dynamics of the model bilayer systems -DOPC representing the mammalian 
membrane, DOPC/POPE = 60/40 mol % and DOPC/POPG = 70/30 mol % respectively, 
mimicking the bacterial membrane- were studied. These experiments provide us with a 
reference for the diffusion coefficients of model membranes.  The evaluation of recorded 
movies revealed that DOPC and DOPC/POPG mixtures exhibit a very similar dynamic 
behaviour (D=5.3±0.4 µm2/s and D=5.0± 0.2µm2/s). This result was not surprising since 
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both DOPC and POPG are in liquid-crystalline phase at experiments temperature. The 
membrane consisting of DOPC/POPE had a lower mobility compared with the other two 
(D=3.7±0.2 µm2/s). This result was expected since PE has a relatively small headgroup, 
which leads to significantly lower area per lipid and in consequence to a high order of the 
hydrocarbon lipid tails and corresponding low lipid mobility, as explained in 3.3.4. 
Besides this, PE was in gel phase at room temperature and PC in the liquid-crystalline 
phase, so a high order was expected. Though, it was not possible to identify 2 diffusion 
coefficients corresponding to the different lipid phases. Probably, because the PE domains 
are too thin to produce a distinct mobility (see Figure 2.2.B from Chapter 2). It should be 
mentioned here that GUVs were prepared without cholesterol which led to a considerably 
higher diffusion coefficient for DOPC. In previous study for TAT peptide, mobility for 
PC/chol membranes was 2.01±0.01 μm2/s. This observation was consistent with the results 
reported in literature, which showed that incorporation of cholesterol into phospholipids 
membrane increased the bilayer thickness and reduced its mobility [87]. 
The CLSM experiments revealed after incubation of GUVs prepared from DOPC with 
2µM NKCS, NKCS-[15-27] and NKCS-[15-27S], no peptide import or accumulation on 
membrane. Also, the experiments with GUVs loaded with different tracers showed no dye 
release, suggesting no interaction with DOPC and implicitly with mammalian membranes. 
These results were supported by Andra et al. [62]. The authors detected by FRET and CD 
no interaction of PC liposomes with NKCS (named NK27 in their paper). Furthermore, 
after particle tracking of NKCS and its variants on DOPC membranes, the diffusion 
coefficients were very similar to those of the membrane, even at high peptide 
concentration (2 µM). This means that only sporadically and for short time the peptide is 
attached to the membrane, but without any relevant interaction.   
In DOPC/POPG membranes, the internalization and accumulation on the GUVs of all 
three peptides was observed. The efflux experiments showed the release solely for AF488 
tracer and NKCS. It seems that only this peptide is able either to induce small pores in PG 
membranes or changes in diffusion constant of the membrane which could lead to the dye 
release. From SPT experiments instead we could conclude that there is no difference in the 
behaviour of all three peptides. We found two diffusion coefficients, one comparable to 
the bilayer mobility and the second significantly reduced, pointing to peptide insertion into 
membrane. This idea is supported by the fact that at high concentration of unlabelled 
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peptide, the mobility of lipids in the membrane is reduced from D=5.0±0.2 to D=3.6±0.5 
µm2/s. Also, the FRET and CD experiments performed by Andra et al. [62] suggested that 
NKCS is intercalated in PG liposomes.  
NKCS, NKCS-[15-27] and NKCS-[15-27S] were internalized into GUVs formed by 
DOPC/POPE as well. They showed also an accumulation on the membrane. Similar to PG 
experiments, the efflux of tracer was observed only for NKCS, but this time besides 
AF488 3 kDa dextran was released too. SPT experiments revealed a deeper insertion 
compared to PG membranes of the peptides into bilayer, since the diffusion coefficients 
for lipid at high concentration of unlabelled peptide are comparable with those of the 
peptide on GUVs. Also the percent of slower component was increased as well.  
Similar results were obtained in presence of 100 mM NaCl, showing that essential for 
peptide activity was the direct interaction with the phospholipids and not existent ions in 
the medium. 
We should underline here that bilayer mobility in presence of 2 µM B-TAT (unlabelled) 
was not changed unlike NKCS. Therefore, because the NKCS peptide induces 
considerable modifications in lipids mobility in GUVs prepared from PG and PE, besides 
the pore formation mechanism, a possible explanation for dye release could be also the 
changed diffusion constants of the membranes.  
Altogether, we can conclude that TAT peptide behave similar to NKCS, inducing pores in 
PE and anionic membranes (PS for TAT and PG for the antimicrobial peptides). Also, for 
PE based GUVs, two diffusion coefficients were detected for both types of peptides, 
suggesting a deep insertion of peptide into the membrane and a similar mechanism. 
Instead, in PG membranes, NKCS and its shorter variants showed two diffusion 
coefficients, in contrast to TAT peptide mobility on GUVs containing PS, whose jump 
distance histograms were fitted with a single component. This observation could indicate a 
possibly different mechanism of action for CPPs and antimicrobial peptides in anionic 
membranes. A noticeable difference between TAT and NKCS was in GUVs prepared 
from PC, only the first one showing interaction and accumulation on this type of 
membrane.  While for the CPP-TAT the ions from medium seemed to play a very 
important role for peptide translocation, NKCS activity was not affected in any way by 
100 mM salt solution. 
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5. Summary and Outlook 
 
The present thesis is a detailed study on interaction of cell-penetrating TAT peptides with 
model membranes in different experimental conditions. The first part of the study was 
focused on direct interaction between TAT peptides and lipids with all ions excluded from 
the medium. We found that while lipid mobility varied clearly with the phase state of the 
membranes, the peptide mobility was independent on membrane hydrophobic core, but 
dependent on lipid headgroups. Confocal experiments showed that TAT peptide 
accumulated without translocation on surface of neutral GUVs formed by PC and 
cholesterol and on anionic GUVs with a content of PS between 15-30 mol %. Introduction 
of a higher amount of anionic lipids (40 mol %) resulted in peptide translocation. In some 
cases TAT provoked membrane destabilization leading to vesicle disruption, an effect 
which could be assigned to a carpet-like lysis mechanism. Furthermore, a clear 
translocation across membranes containing 20 mol % of lipids known to induce a negative 
curvature (PE) was observed. In both cases, TAT peptides were capable to form 
nanometres-sized pores, which could be passed by small but not large dye tracer 
molecules.  
In the second part of the thesis, the influence of ions on TAT peptides translocation was 
studied. CLSM experiments showed that in presence of 100 mM NaCl solution the TAT 
interaction with the GUVs membrane was completely altered. Any detectable TAT 
binding to GUVs was entirely lost while the peptides translocated efficiently into the 
vesicles interior. The experiments with GUVs loaded with dyes of different molecular 
weights sustained again a pore formation in presence of 2 µM TAT and 100 mM NaCl. 
The result was similar for neutral and anionic, liquid-ordered and liquid-disordered 
membranes. Also, there was no difference in TAT behaviour for GUVs without 
cholesterol or in case of other salt solutions at the same concentration, 100 mM (CaCl2, 
CaCO3 or PBS). In this case we assumed that TAT formed ion-pairs between the 
guanidinium groups and phosphate counter ions from lipid headgroups and then a 
membrane potential enabled the peptides translocation and pore formation. 
To summarize, we found that internalization of TAT in membrane depends on: amount of 
charge in the headgroups, negative curvature of involved lipids, e.g molar ratio of PE, ions 
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present in the medium. In all cases where the translocation was observed, a pore formation 
by TAT can be concluded. 
In the last part of this thesis interaction of NKCS antimicrobial peptides, which 
supposedly act by membrane pore formation, with model membranes was studied. We 
observed that TAT peptides behaved similar to NKCS, inducing pores in PE and anionic 
membranes (PS for TAT and PG for the antimicrobial peptides). A clear difference 
between TAT and NKCS was in GUVs prepared from PC, only CPPs showing interaction 
and accumulation on this type of membrane.  Also for TAT the ions from medium seemed 
to play a very important role for peptide translocation, but NKCS activity was not 
influenced by 100 mM salt solution. 
TAT peptides represent a powerful tool for the development of cell-permeable agents. 
Their property to deliver a broad variety of cargoes inside of the cells is well-known. A 
perspective for this thesis might be to study the interaction of TAT peptide conjugated to 
different types of molecules with GUVs. This could clarify hipothesys that passive 
mechanism of translocation is valid for small molecules, while big cargoes attached to 
TAT are internalised by active endocytosis.  
The experiments presented in this thesis showed that TAT peptides internalization is 
favoured by PE and PS. PE is a lipid frequently occurring in bacterial membranes and PS 
is a lipid present at high concentration in the outer membrane leaflet of cancer cells. A 
further study might be to test TAT for antimicrobial properties and anticancer activity. So, 
besides numerous applications of TAT peptide as powerful delivery agent for biology, 
imaging and biotechnology, these additional applications for therapeutics and medicine 
should be considered as well.  
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